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ABSTRACT

NOVEL BAYESIAN METHODOLOGY FOR THE ANALYSIS OF
SINGLE-CELL RNA SEQUENCING DATA
Michael Sekula
April 10, 2020
With single-cell RNA sequencing (scRNA-seq) technology, researchers are able to gain
a better understanding of health and disease through the analysis of gene expression
data at the cellular-level; however, scRNA-seq data tend to have high proportions
of zero values, increased cell-to-cell variability, and overdispersion due to abnormally
large expression counts, which create new statistical problems that need to be addressed. This dissertation includes three research projects that propose Bayesian
methodology suitable for scRNA-seq analysis. In the first project, a hurdle model
for identifying differentially expressed genes across cell types in scRNA-seq data is
presented. This model incorporates a correlated random effects structure based on an
initial clustering of cells to capture the cell-to-cell variability within treatment groups
but can easily be adapted to an independent random effect structure if needed. A
sparse Bayesian factor model is introduced in the second project to uncover network
structures associated with genes in scRNA-seq data. Latent factors impact the gene
expression values for each cell and provide flexibility to account for the common features of scRNA-seq. The third project expands upon this latent factor model to allow
for the comparison of networks across different treatment groups.
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CHAPTER 1
INTRODUCTION
For over a decade, RNA sequencing technologies have been instrumental in transforming our knowledge and understanding of transcriptomes. The analysis of data
generated by these technologies has led to a plethora of novel biological findings
ranging from the discovery of new transcripts to the identification of genes associated
with specific diseases (Wang et al., 2009; Liu et al., 2015). Currently, RNA sequencing experiments fall into one of two categories: bulk RNA sequencing (RNA-seq)
or single-cell RNA sequencing (scRNA-seq). Traditional bulk RNA-seq experiments
examine transcript abundance measurements that have been averaged over populations of thousands, or even millions, of cells. In contrast, the more recent scRNA-seq
experiments examine gene expressions from individual cells. While bulk RNA-seq
studies have a longer history in the literature, scRNA-seq studies are rapidly gaining
attention among researchers today.
What makes the future of scRNA-seq so promising is the unprecedented opportunity to thoroughly investigate cellular functionality at the level of a single cell.
Diverse gene expression patterns in cell populations that have previously seemed
homogeneous are becoming exposed, allowing investigators to uncover solutions to
unanswered questions across various fields of biology (Shapiro et al., 2013; Fan et al.,
2015; Kanter and Kalisky, 2015). Nevertheless, the information collected from singlecell sequencing does present new computational and statistical challenges. Several
intrinsic features of scRNA-seq data are not observed in bulk RNA-seq data (Figure
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1.1), and so many of the well-established methods used in bulk RNA-seq studies are
not suitable for scRNA-seq studies. Thus, in order to take full advantage of scRNAseq technologies, new statistical techniques need to be developed (Stegle et al., 2015;
Bacher and Kendziorski, 2016).
Perhaps the most distinct characteristic of data generated by scRNA-seq is
the abundance of zeros (Figure 1.1A). Specifically, the expression values of transcripts often exhibit bimodal distributions (Figure 1.1B) such that a gene can have
high expression values for some cells but not be expressed in others (Shalek et al.,
2013; Kharchenko et al., 2014). Although these expression patterns are due in part
to technical variation and low concentrations of mRNA, they are also attributed
to true biological differences between populations (or even subpopulations) of cells
(Macaulay and Voet, 2014; Finak et al., 2015). Unimodal distributions typically used
for the analysis of bulk RNA-seq data fail to capture the complex structure of scRNAseq data, which bolsters the need for developing new methods specific to single-cell
analyses.
Another prominent feature of scRNA-seq data is the increased cell-to-cell variability (Figure 1.1C). Since information is being gathered from individual cells, differences in gene expressions across a single cellular population can now be observed.
This means variation in scRNA-seq data can exist both between different groups of
cells and within the same cellular population (Huang, 2009; Buettner et al., 2015; Korthauer et al., 2016; Tirosh et al., 2016). Traditional bulk RNA-seq experiments often
mask this heterogeneity by averaging out the gene expression measurements, and for
that reason, bulk RNA-seq methods do not directly take the high cell-to-cell variation associated with scRNA-seq into consideration. Here, the need for new single-cell
analysis methods is again highlighted by the inability of bulk RNA-seq methods to
appropriately address the unique characteristics of scRNA-seq data.
Many of the tasks performed in bulk RNA-seq studies, such as detecting genes
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that are differentially expressed between different populations of cells or constructing biological networks of genes within a population of cells, are also performed in
scRNA-seq studies. Moreover, there are some tasks, such as identifying subpopulations of cells, that are unique to scRNA-seq experiments. Since bulk methods are not
appropriate for analyzing single-cell data, new analytic tools specific to scRNA-seq
are in high demand. The development of novel statistical techniques for the analysis
of scRNA-seq data is gaining much attention, and research in this area is moving
quickly. Some progress has already been made in this emerging area of research, but
numerous opportunities still exist for the development of new single-cell methodology.

1.1 Differential Expression of Single-cell RNA Sequencing Data
A commonly performed task in sequencing analysis is the identification of genes that
are differentially expressed (DE) across different populations of cells. Two of the most
commonly referenced methods that have been designed specifically for differential
expression analysis of scRNA-seq data are Single-Cell Differential Expression (SCDE;
Kharchenko et al., 2014) and Model-based Analysis of Single-cell Transcriptomics
(MAST; Finak et al., 2015). SCDE generates error models for each gene by using
a mixture of a low-level Poisson distribution and a negative binomial distribution.
The Poisson distribution is used to capture genes that are undetected across some
of the cells, and the negative binomial distribution is used to address overdispersed
expression counts commonly observed in sequencing data. MAST uses a two-part
generalized linear model (hurdle model) to analyze continuous scRNA-seq expression
levels, as opposed to analyzing discrete count values like SCDE. A logistic regression
is initially used to model the proportion of cells that express a given gene, thereby
addressing the overinflation of zeros observed in scRNA-seq data. Then, if a gene is
expressed within a cell, a Gaussian distribution models the transformed expression
level.
3

More recently, several other methods for detecting DE genes in scRNA-seq
have also been proposed. The Beta-Poisson Single-Cell (BPSC) method in Vu et al.
(2016) uses a generalized linear model framework with a beta-Poisson mixture model
to compare mean expression values across cellular groups. Delmans and Hemberg
(2016) introduced the Discrete, Distributional method for Differential gene Expression (D3 E), which also uses a beta-Poisson mixture model but compares gene expression distributions using either the Kolmogorov-Smirnov test, the Cramér-von Mises
test, or the likelihood ratio test. A zero-inflated negative binomial model is utilized
in DEsingle (Miao et al., 2018) to detect DE genes with likelihood ratio tests and
estimate proportions of true zeros and dropout zeros.
Surprisingly, despite the variety of methods designed for differential expression
analysis of scRNA-seq data, several studies have concluded that these methods do
not perform much better than the bulk RNA-seq methods (Jaakkola et al., 2017;
Miao and Zhang, 2016; Soneson and Robinson, 2018). Therefore, opportunities still
exist for developing new methodology that will significantly outperform the bulk
methods. In Chapter 2, a novel statistical model for high dimensional and zeroinflated scRNA-seq count data is introduced to identify differentially expressed genes
across cell types. We adopt a hurdle model to address the overabundance of zeros
in scRNA-seq data, and employ a correlated random effects structure guided by an
initial supervised subpopulation clustering assignment to capture the observed cellular
variability within treatment groups of cells.

1.2 Network Inference from Single-cell Gene Expression Data
Another common task in sequencing analysis is the construction of networks of genes
with similar biological processes. These networks, which are often classified as either gene co-expression networks (GCNs) or gene regulatory networks (GRNs), provide valuable insight into the functionality and mechanics of biological processes. In
4

GCNs, the edges that connect nodes (genes) within the network are considered to be
“undirected” since they only indicate the relationships or dependencies between the
co-expression of genes, not the underlying cause of these associations. This makes
GCNs slightly different from GRNs, which connect nodes with directed edges that can
be used to infer casual relationships (De Smet and Marchal, 2010). Network analysis
is an important tool in the biomedical sciences because genes involved in the same
biological pathway or have similar functionality tend to also have similar expression
patterns (Eisen et al., 1998; Allocco et al., 2004). By examining GCNs and GRNs,
researchers can gain a better understanding of the relationships and interactions between sets of genes during different cellular functions and processes (Wolfe et al.,
2005; Hecker et al., 2009; Wang et al., 2016).
Interestingly, research in designing new methodology for scRNA-seq gene networking analysis has only recently been gaining attention in the literature. Lag-based
Expression Association for Pseudotime-series (LEAP; Specht and Li, 2016) is a GCN
method that determines gene co-expression by taking into account the possible lags
in time that can be caused by cells being in different time points of their cell cycles.
Introduced by Aibar et al. (2017), Single-Cell rEgulatory Network Inference and Clustering (SCENIC) constructs GRNs by first detecting potential sets of co-expressed
genes within a population of cells and then performing a transcript factor enrichment
analysis to identify and score significantly enriched gene sets. The Single-Cell Ordinary Differentiation Equation (SCODE) algorithm from Matsumoto et al. (2017)
uses linear ordinary differentiation equations to obtain an optimized square matrix
that represents the regulatory relationships between transcription factors. Partial
Information Decomposition and Context (PIDC; Chan et al., 2017) is an information
theory based algorithm that utilizes partial information decomposition to identify
GRNs.
Like the DE methods for scRNA-seq, the current network methods for scRNA-
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seq do not outperform methods developed for bulk RNA-seq data (Chen and Mar,
2018). Thus, new network methods applicable to scRNA-seq data need to be developed. In Chapter 3, a sparse Bayesian latent factor model is presented to explore the
network structure associated with genes in a single population of cells. For a given
cell, a set of shared latent factors adjusts the expression value for each gene, thereby
accounting for the zero-inflation and overdispersion commonly observed in scRNA-seq
data. A network structure is then inferred from the common factors between pairs of
genes that impact their expressions.

1.3 Single-cell Differential Network Analysis
Methods for constructing GCNs and GRNs typically assume that the network structure is being explored within one population of cells such as a single tissue type,
environmental condition, or disease status. For some biological studies, however, it
may be of greater interest to compare structures from different cellular populations.
Different types of cells, or the same type of cell in different stages or conditions, may
carry out different functions, and by performing differential network analysis between
two (or more) gene-gene association or interaction networks, researchers can identify
the parts of the network that are affected by these biological differences.
Most methods for examining differences between gene network structures have
been developed in the context of microarray and bulk RNA-seq data. To our knowledge, the literature related to methodology developed for scRNA-seq differential network analysis is quite sparse. In fact, Chowdhury et al. (2019) provide an extensive
review on differential co-expression analysis of gene expression data that highlights
the need for more research in scRNA-seq methodolgy. The statistical framework developed by Gill et al. (2010) for microarray gene expression data was utilized in Wang
et al. (2017) to present proof-of-concept analyses for comparing network structures
constructed from scRNA-seq data. Chiu et al. (2018) introduced the scRNA-seq-based
6

differential network (scdNet) analysis method to determine a sample size corrected
gene-gene correlation matrix for each cellular state and identify gene-gene pairs that
have significant changes between these states. The authors claim that scdNet is the
first tool for differential network analysis of scRNA-seq data.
In Chapter 4, we expand upon the network model proposed in Chapter 3 to examine differences in the underlying networks across two separate cellular populations.
Under this model, the parameters that influence the latent factors are treatmentdependent to allow gene-gene co-expression calculations within each group of cells.
The gene network structures can then be compared by analyzing credible intervals of
the differences between the co-expressions of each group.

7

1.4 Figures

Figure 1.1: Comparisons between bulk RNA-seq and scRNA-seq data. (A) Proportion
of zeros boxplots from a bulk (bulk1) and a single-cell (sc1) dataset. For each type
of RNA-seq data, genes were sorted by their median expression values and groups
were formed based on percentiles. (B) Estimated number of modes for the expression
distributions of 1,000 randomly selected genes from three bulk and three scRNA-seq
datasets. (C) Log variance density plots for all of the genes in the datasets from B.
Densities were also created for the log variance of the scRNA-seq datasets when zeros
were removed to illustrate the variation across the non-zero expression values.
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CHAPTER 2
DETECTION OF DIFFERENTIALLY EXPRESSED GENES IN
DISCRETE SINGLE-CELL RNA SEQUENCING DATA USING A
HURDLE MODEL WITH CORRELATED RANDOM EFFECTS1

2.1 Introduction
Rapidly emerging advances in next-generation technology have pushed single-cell
analysis to the forefront of gene expression profiling experiments. Traditionally, transcriptomic studies have examined transcript abundance measurements averaged over
bulk populations of thousands of cells. While bulk RNA sequencing (RNA-seq) measurements have been valuable in countless studies, they often conceal cell-specific heterogeneity in expression signals that may be paramount to new biological findings.
Fortunately, with single-cell RNA sequencing (scRNA-seq), transcriptome data from
individual cells are now accessible, providing opportunities to investigate functional
states of cells, identify rare cell populations, and uncover diverse gene expression patterns in seemingly homogeneous cell populations (Huang, 2009; Shapiro et al., 2013;
Buettner et al., 2015).
One of the most commonly performed tasks in transcriptome expression profiling is the identification of genes that are differentially expressed (DE) across different biological conditions, treatment groups, or cell types. For consistency in this
1

Reproduced with permission from “Detection of differentially expressed genes in discrete singlecell RNA sequencing data using a hurdle model with correlated random effects” by Michael Sekula,
Jeremy Gaskins, and Susmita Datta, 2019. Biometrics. DOI:10.1111/biom.13074.
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manuscript, we will refer to the populations of cells being compared in a differential expression analysis as treatment groups. Several popular methods for differential
expression analysis of traditional bulk RNA-seq datasets currently exist, but these
methods fail to capture the intrinsic characteristics that differentiate scRNA-seq data.
The most prominent attribute of scRNA-seq is that a transcript can be moderately or highly expressed in some of the individual cells but not detected in others, resulting in a bimodal distribution of expression values (Shalek et al., 2013; Kharchenko
et al., 2014). This expression pattern is caused by the low starting amounts of mRNA
within each individual cell in combination with variation from biological and technical
sources (Macaulay and Voet, 2014; Finak et al., 2015). The unimodal distributions
used for the traditional differential expression analysis of RNA-seq data do not properly model this inherent bimodal structure of scRNA-seq data. In addition, cell-to-cell
variability in scRNA-seq has been shown to exist not only between different cellular
populations but also within the same population of cells (Huang, 2009; Buettner et al.,
2015). This observed heterogeneity is not directly addressed in traditional RNA-seq
differential expression methods.
Because scRNA-seq datasets exhibit properties different from bulk RNA-seq
datasets, new techniques for identifying DE genes specific to scRNA-seq data need to
be developed (Stegle et al., 2015; Bacher and Kendziorski, 2016). Two commonly used
methods that have been proposed to identify DE genes while taking into consideration
the intricate nature of scRNA-seq data are SCDE (Kharchenko et al., 2014) and
MAST (Finak et al., 2015). With the SCDE method, error models for each gene
are first modeled using a mixture of a negative binomial distribution (to account for
overdispersed expression counts from detected transcripts) and a low-level Poisson
distribution (to accommodate genes that are undetected across some of the cells).
Posterior probabilities of a given fold expression difference are then calculated to
test genes for differential expression between two subgroups of cells. MAST is a
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two-part generalized linear model (hurdle model) that analyzes continuous scRNAseq expression levels, rather than discrete count values. A logistic regression first
models the gene expression rate, and, conditioning on a cell expressing the given
gene, a Gaussian distribution models the transformed expression level. Differential
expression can then be tested using a likelihood ratio test.
In our view, a hurdle model structure (like MAST) is the best way to model
such data with an overabundance of zeros. The components of a hurdle model are
regression models (one for zero counts and one for expression values), which makes
parameter estimation fairly straightforward and computationally simple compared to
other types of methods. With a two component model, one can distinguish whether
differences between treatment groups come from differences in the proportion of zeros,
differences in actual expression, or both. Moreover, hurdle models are flexible and can
adjust for potential experimental bias, such as dropout or cell size, with the addition
of biological and/or technical covariates.
Rather than transforming the scRNA expression counts to continuous variables
(as required in MAST), we adopt the hurdle model approach to directly model the
discrete data. Consequently, we propose a mixed effect hurdle model for discrete
scRNA-seq gene expression counts to detect genes that are DE between different
treatment groups. The expression rate for a particular gene is first modeled with
logistic regression to account for the high proportion of zeros in scRNA-seq data,
and the expression count is then modeled with a zero-truncated negative binomial
regression, conditional on the gene actually being expressed. Besides using discrete
count data, another key difference between MAST and our proposed methodology is
the incorporation of cell heterogeneity in a supervised manner. We utilize a random
effects structure, guided by subpopulations of cells, to provide dependence across
genes within a cell and across cells of a subpopulation. Finally, the third major
difference between our method and MAST is that we implement a Bayesian approach
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to estimate model parameters.
This manuscript is organized as follows. We define the hurdle model and
introduce the structure of the correlated random effects (CRE) in Section 2.2. In
Section 2.3, we present the methods for estimating model parameters and determining
DE genes. Our proposed methodology is applied to both simulated and real data
in Section 2.4, where we also compare the performance of our methodology to the
performance of other commonly used methods for detecting DE genes. Finally, we
conclude with a brief discussion of our results in Section 2.5.

2.2 Methodology
2.2.1 Model Structure
Let Ygi be the expression count of gene g (g = 1, ..., G) in cell i (i = 1, ..., N ), and Zgi
indicate whether the gene is expressed within the cell. With this definition, Zgi = 1
when Ygi > 0, and Zgi = 0 when Ygi = 0. Defining θgi = P (Zgi = 1), the indicator
variable Zgi follows Bernoulli(θgi ), and the logistic model is defined as
L
logit(θgi ) = β0g
+ Xi βgL + ωi ζgL ,

(2.1)

where Xi is a row from the design matrix consisting of a treatment group indicator
and any other covariates of interest, such as cell size or estimated dropout rate. In
Equation (2.1), we present the general case where Xi has more than one element,
hence βgL is a vector of regression coefficients. Also, we use the superscript L on the
coefficients from the logistic model to distinguish them from the coefficients in the
zero-truncated negative binomial regression.
The random effect ωi for cell i is included in the model to account for additional
variability between cells and to induce correlation across genes. Depending on the
particular gene, cellular random effects may have more or less of a predictive influence,
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thus, we introduce a coefficient for the random effects ζgL to represent a gene specific
scaling factor for the random effects within the logistic regression component.
For the conditional expression counts, we define the negative binomial distribution as

y 
φg
Γ(y + φg )
µgi
φg
P (Ygi = y) =
,
y!Γ(φg ) µgi + φg
µgi + φg

y = 0, 1, . . . ,

where µgi , φg > 0. Under this set-up, E(Y ) = µgi and V ar(Y ) = µgi +

(2.2)
µ2gi
,
φg

mak-

ing φg the overdispersion parameter. A modification to Equation (2.2) is needed to
account for conditioning on a non-zero expression count (Ygi > 0); therefore, the
zero-truncated negative binomial distribution is defined as
Γ(y+φg )
y!Γ(φg )



µgi
µgi +φg

P (Ygi = y|Zgi = 1) =


1−

y 

φg
µgi +φg

φg
µgi +φg

 φg

 φg
,

y = 1, 2, . . . , .

(2.3)

Using the distribution in (2.3), we have the following regression model for
conditional expression counts:

C
log(µgi ) = β0g
+ Xi βgC + ωi ζgC .

(2.4)

Here, the superscript C indicates the coefficients in the count model (zero-truncated
negative binomial regression). With this hurdle component, the regression coefficients
in (2.4) can be interpreted as approximately representing a multiplicative effect on the
C
expression count. Thus, if Xi1 is a dummy variable for the treatment indicator, β1g

(the first element of vector βgC ) would approximately represent the log-fold change.
The same random effect (ωi ) used in the logistic model is also used here to control
dependence across genes and dependence with the logistic model. The coefficient of
the random effects ζgC is representative of a scaling factor for ωi per gene within the
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truncated negative binomial regression component.

2.2.2 Correlated Random Effects
It has been observed that within defined treatment groups of scRNA-seq experiments
there exist subpopulations of cells with different expression patterns across different
genes (Huang, 2009; Buettner et al., 2015). In order to account for this observation,
we assume that the random effects of cells within a subpopulation are positively
correlated, but between subpopulations, the random effects are independent. We
refer to this model as CRE.
Before utilizing our CRE model, cells within each treatment group need to be
clustered separately to form K0 subpopulations in the control group and K1 subpopulations in the treatment group. These subpopulation clusters can be identified with
a suitable scRNA-seq clustering algorithm and then applied to our model structure.
We must emphasize that our focus is not on how to perform a cluster analysis, but
rather on how the results from a cluster analysis are incorporated into our model.
Therefore, we assume that best practices (e.g., normalization, batch effect adjustments, etc.) have been followed before clustering to avoid additional influence of any
biological and/or technical bias on the differential expression results.
Letting kt (i) indicate the cluster assignment for cell i in treatment t, we have
k0 (i) and k1 (i) representing the clusters/subpopulations within the control group and
treatment group, respectively. Using this notation, each cellular random effect ωi is
defined as the sum of two separate components: ωi = γt,kt (i) +ωi∗ . Here, γt,k represents
the average random effect for the subpopulation k within treatment t, and ωi∗ is the
individual cellular adjustment for cell i within the subpopulation. With each γt,k
following an independent and identically distributed (i.i.d.) Normal(0, σt2 ) and each
ωi∗ following an i.i.d. Normal(0, σ∗2 ), the correlation, ρt , between cells within the same
subpopulation is then ρt =

σt2
.
σt2 +σ∗2

14

We note that the random effect ωi enters into the model through the terms
ωi ζgL and ωi ζgC . As ωi , ζgL , and ζgC are all estimated parameters, the individual ωi ’s
are, therefore, scale-unidentified. However, the relative contribution of γt,kt (i) to ωi is
identifiable, as will be the correlation ρt . To facilitate interpretation, the estimated
ωi ’s can be post hoc rescaled to have variance one.
For special cases, such as datasets with large numbers of cells, or situations
when an initial clustering is not preferred, the correlations between random effects can
be removed and one can simply assume that all of the random effects are independent
of each other. Under this assumption, each ωi simply follows an i.i.d. Normal(0, σ 2 ).
We refer to this model choice as independent random effects (IRE).

2.3 Model Inference
2.3.1 Parameter Estimation
A Bayesian approach is utilized to estimate the parameters of our proposed model.
While a seemingly straight-forward technique for obtaining these parameter estimates
is Markov chain Monte Carlo (MCMC) sampling, it may take days of computational
time for this iterative process to generate enough samples to reasonably estimate our
model parameters on large scRNA-seq datasets. This makes an MCMC approach
impractical compared to the computational time of methods currently available for
identifying DE genes. If time is not a factor, researchers may still choose to utilize
full MCMC to obtain parameter estimates and model inference.
Instead of time-consuming MCMC, we use variational inference (VI) to approximate the posterior distribution and obtain parameter estimates more quickly.
VI has been recently proposed as a computationally faster alternative to MCMC for
solving Bayesian problems involving large data (Blei et al., 2017). Briefly, mean-field
variational Bayes approximates the usual posterior distribution p(Θ|y) with a distri-
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Q
bution q(Θ) that assumes all components of Θ are independent, q(Θ) = j qj (Θj ).
Q
This leads to an optimization problem of finding the q(Θ) = j qj (Θj ) that is closest
in Kullback-Leibler divergence to the true posterior.
Introduced by Kucukelbir et al. (2015), automatic differentiation variational
inference (ADVI) is a user-friendly method that automatically generates an algorithm
to solve this optimization problem. In essence, each qj (·) is assumed to be a normal
distribution on a suitable transformation of Θj . Optimizing the parameters of these
normal distributions is accomplished using a stochastic gradient ascent algorithm to
maximize the evidence lower bound (ELBO). Monte Carlo integration approximates
the expectations of the ELBO and automatic differentiation computes the gradients that are maximized. We implement the mean-field algorithm of ADVI in R (R
Core Team, 2018) through the package rstan (Stan Development Team, 2018). After
achieving convergence to the approximate posterior with rstan’s ADVI algorithm,
parameter samples are drawn independently from q(Θ) and provided to the user as
approximate posterior samples from p(Θ|y).
To complete the specification of our Bayesian model, we need prior distributions for the remaining parameters. The regression coefficients in both the logistic
regression and the zero-truncated negative binomial regression are given weakly informative Cauchy priors (Gelman et al., 2008). The intercept terms have Cauchy(0, 10)
priors, while the remaining coefficients have Cauchy(0, 2.5) priors. The lognormal
distribution is used as the prior for the overdispersion parameter φg , with the hyperparameters λ1 and λ2 defined as
φg ∼ Lognormal(λ1 , λ2 ),
λ1 ∼ Cauchy(0, 10),
λ2 ∼ Inverse Gamma(0.001, 0.001).
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Sensitivity analysis with the case study data (see Appendix D) indicates replacing the
λ2 prior with Inverse Gamma(1, 1) has little effect on the final differential expression
results. In addition, the variance parameters for the cellular random effects, σt2 and σ∗2 ,
have Inverse Gamma(1, 1) priors. By choosing this prior for the variance parameters,
the prior for ρt , the correlation between cells within the same cluster, is Beta(1, 1).
2.3.2 Testing for Differential Expression
Typically, the target of inference in scRNA-seq studies is to determine if genes from
two treatments are “differentially expressed” (DE), that is, they follow different distributions. In our modeling framework, the difference in the distributions between
L
C
treatments is controlled by the pair of regression coefficients β1g
and β1g
of the treat-

ment group indicator. A gene is considered to be DE if at least one of these parameC
L
= 0 against the alternative.
= β1g
ters is non-zero. That is, we need to test H0 : β1g

While we develop our model and estimate parameters under the Bayesian paradigm,
we choose to perform hypothesis testing under the standard frequentist framework as
most researchers are more familiar with this approach.
cg to be the two-dimensional vector consisting of the point estimates
We define B
c
C
L
of βc
1g and β1g (the treatment effect coefficients from the logistic and count models
for gene g), and let Vg represent the estimate of the covariance matrix, as determined
empirically from the posterior samples (provided as output by Stan) of these two
coefficients. Wang and Blei (2019) have established that the variational posterior
q(Θ) is asymptotically normal with a random mean centered at the true parameter
L
C
value. Thus, under the null hypothesis that β1g
= β1g
= 0, the test statistic Wg =

cg T V −1 B
cg will asymptotically follow a chi-square distribution with two degrees of
B
g
freedom. If Wg is larger than the appropriate critical value, we reject H0 and conclude
that gene g is differentially expressed; a p-value can also be obtained.
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2.4 Applications
2.4.1 Simulation Studies
To evaluate performance, we applied our method to simulated data generated from
our proposed model. We considered scenarios when the true subpopulations had equal
sizes (same number of cells per subpopulation) and unequal sizes (different number
of cells per subpopulation). An additional simulation was run using data generated
with the Splat simulation design (Zappia et al., 2017) to evaluate the performance
of our models on data simulated from a structure that differs from our proposed
methodology. Small datasets (100 cells and 10,000 genes) were analyzed to illustrate
the feasibility of our methods, while larger datasets (1,000 cells and 10,000 genes) were
analyzed to demonstrate their practical utility. Details on these simulation designs
are available in the Appendix.
Two versions of the proposed hurdle model, the CRE model and the IRE
model, were evaluated under these different simulation scenarios. In our model matrix, we included the treatment group indicator and the cellular detection rate (CDR)
as covariates. The CDR for cell i is the sample proportion of genes that have a nonzero count,
G

1 X
Zgi ,
CDRi =
G g=1

(2.5)

and has been presented by Finak et al. (2015) as an important source of variability
that captures variation due to biological and technical factors, such as cell volume
and dropout. Since our model does not inherently distinguish between true biological
zeros and technical zeros, including CDR as a covariate will help control for expression
differences due to these unwanted sources of variation. To demonstrate that the
addition of random effects actually improves upon a model that includes CDR, we
also tested our proposed methodology using only fixed effects (i.e., removing the ωi ζg
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terms from (2.1) and (2.4)). We refer to this model as no random effects (NRE).
When applying the CRE model, clusters within each treatment group were assigned by the SNN-Cliq algorithm (Xu and Su, 2015) and the SC3 algorithm (Kiselev
et al., 2017). SNN-Cliq requires the number of nearest neighbors to find a clustering
structure, and so the number of nearest neighbors was set to the default value of three.
We also set the number of nearest neighbors to seven in the hurdle model simulations
to obtain fewer numbers of clusters within each treatment group. Since the Splat
simulation does not inherently create subpopulations, we only considered three nearest neighbors. The SC3 algorithm, on the other hand, requires the number of clusters
to be specified. Therefore, we utilized SC3’s option to estimate the optimal number
of clusters for each treatment group in each simulated dataset. As an alternative
clustering option in the hurdle model simulations, we also estimated the model under
the true data-generating subpopulation assignments to gauge performance when the
actual clustering structure is known.
In addition to evaluating the performance of our methodology, we also compare
our proposed models to methods commonly used in the literature. The methods
for scRNA-seq differential expression of MAST and SCDE were examined in these
studies along with two methods designed for bulk RNA-seq differential expression:
edgeR (Robinson and Smyth, 2007) and DESeq2 (Love et al., 2014). The covariate of
CDR was also implimented in the model matrix for MAST as described in the MAST
package vignette for the MAIT data analysis (McDavid et al., 2019).
Instead of utilizing raw discrete counts, the two clustering algorithms and
MAST require continuous expression data. To that end, a trimmed mean of M-values
normalization was first applied to the simulated datasets to account for betweensample bias, and the adjusted count values were then scaled to counts per million
with the edgeR package (2019), thereby accounting for differences in library size.
In this simulation analysis, 100 datasets were generated for all scenarios, and
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DE genes were determined at a false discovery rate (FDR) of 0.05 for each method.
We used the measures of true positive rate (TPR), false positive rate (FPR), observed
FDR, area under the receiver operating characteristic curve (AUC), and the number
of identified DE genes to compare methods. Summaries of these measures for all
simulations are provided in Table 2.1.
In all hurdle model simulations, the NRE model was unable to control FDR
at a nominal rate and had approximately twice the FDR as both CRE and IRE.
This result was observed even when the “true” subpopulation structures were simulated with different numbers of clusters and with higher within-cluster correlations
(Appendix A). Therefore, the addition of random effects to our methodology helps
control the FDR when underlying subpopulations exist. When comparing the random
effects models, CRE and IRE have similar performances in the smaller hurdle model
simulations, with CRE having slightly lower FDRs. However, this difference becomes
more evident in the larger datasets. Hence, the correlated random effects do a better
job at controlling the FDR to a nominal level than the independent random effects.
Moreover, the correlation structure of CRE is quite robust as the performance of this
method is generally unaffected by the initial clustering of cells within each treatment
group.
Even though the Splat design does not simulate a subpopulation structure,
CRE and IRE still obtain higher TPRs and larger numbers of detected DE genes
compared to NRE. Additionally, the Splat simulations demonstrate that bias is not
introduced if a clustering structure is input into CRE when the dataset does not
inherently have “true” subpopulations. In fact, the results from IRE and CRE are
nearly identical in the larger Splat simulation.
When comparing our methodology to the other methods for detecting DE
genes, CRE and IRE consistently identified large numbers of DE genes with high
power (TPR), and detected more DE genes than MAST across all simulations. The
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FDR of our models is well maintained at the nominal level (as is MAST), but SCDE
and the bulk methods consistently fail to control FDR. Regarding the AUC, our
method outperforms the competing approaches (both bulk and scRNA) across all
scenarios. Because it also relies on a hurdle model specification, we do note that
MAST is somewhat competitive in AUC when the data-generating mechanism is our
hurdle model. Nevertheless, MAST performed poorly in the Splat simulations as it
had the lowest AUC out of all the considered methods. These overall trends were
also observed when different subpopulation structures were simulated (Appendix A).

2.4.2 Case Studies
To further illustrate our proposed methods, we analyzed the mouse embryonic cell
(MEC) dataset (Islam et al., 2011), which contains expression counts of 92 single-cells
generated from two different cell types: 48 stem cells and 44 fibroblast cells. This
dataset was obtained from the Gene Expression Omnibus (GEO) database under
accession number GSE29087. Genes not expressed in at least 20% of the cells were
removed, leaving 7,912 genes in the analysis. SNN-Cliq with five nearest neighbors
was used to generate cluster assignments within each treatment group to form three
clusters within the stem cells and two clusters within the fibroblast cells for input
into our CRE model. It has been noted that if the number of nearest neighbors is
too large, clusters formed by SNN-Cliq may not be thoroughly separated, and if the
number of nearest neighbors is too small, a true cluster may be split into multiple
parts (Xu and Su, 2015). Based on visual inspections of different SNN-Cliq clustering
assignments, we determined that five nearest neighbors was a reasonable choice (not
too small, not too large) for clustering this particular dataset.
We also analyzed a Drop-seq dataset containing single-cell expressions of 2,000
human mammary epithelial cells (HMEC) expressing either exogenous wild type or
mutant histone H2B to demonstrate the utility and scalability of our methods on big
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data. Details of the Drop-seq procedure are provided in Appendix C. This dataset is
quite sparse, so we chose to filter out genes not expressed in at least 50 cells (2.5%
of the total cells), leaving a total of 3,139 genes in the analysis. Four cells from
the dataset were also removed because they had a library size of zero after gene
filtering. To define the random effect structure of CRE, we utilized SC3 to cluster
the 999 wild type cells into seven subpopulations and the 997 mutant cells into nine
subpopulations. These clustering results were taken from a previous cluster analysis
performed on this data by our research group (see Appendix C).
The differential expression methods used in the simulation studies, excluding
NRE, were run in R independently using a single core of a system with an Intel
Core i7 processor (3.5 GHz) and 8 GB of RAM. Based on the results in Table 2.2,
the computational time required for our methods is very reasonable for a Bayesian
analysis on datasets of these sizes. MCMC sampling would take days of running time
before obtaining enough samples for an appropriate analysis. While both CRE and
IRE take longer than the other methods on the smaller MEC dataset, they do scale
better, and are also faster, than SCDE and DESeq2 on the larger HMEC data.
In terms of the number of DE genes detected, CRE and IRE performed similarly in the case studies, which is consistent with the simulation results. CRE identified 4,927 and 1,698 DE genes in the MEC and HMEC datasets, respectively, while
IRE identified 4,947 and 1,696 genes. The overlap of genes was also very high in
the case studies for these methods (4,808 in the MEC data, and 1,640 in the HMEC
data). Nevertheless, the simulation studies do show that CRE outperforms IRE in
terms of FDR, especially in larger datasets. For that reason, we focus the rest of our
discussion in this section on interpreting the CRE results.
Figure 2.1 displays the UpSet plots (Lex et al., 2014) for the intersection of
DE genes identified by the different methods in the MEC and HMEC analyses. Just
like the simulation studies, our method detects a larger number of DE genes than
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most methods in these case studies. In the MEC data, CRE detected the most DE
genes, and surprisingly, the other two scRNA-seq methods detected fewest DE genes.
CRE was second, only to edgeR, in the number of identified DE genes in the HMEC
dataset, while DESeq2 detected very few DE genes compared to the other methods.
As CRE identified a large number of unique DE genes in the MEC analysis
relative to the competing models, we further examined the 1,335 genes uniquely
identified as DE by CRE to determine if they have any biological relevancy. For
comparison purposes, we also examined the 293 genes identified only by edgeR and
the 172 genes detected only by DESeq2 (Appendix D). We found that the subset of
genes detected by CRE are associated with more clusters of enriched gene ontology
(GO) categories than the subsets of genes detected by the other two methods. Thus,
not only is CRE able to identify a larger number of DE genes, but these genes also
have roles in similar biological functions and processes.
From a statistical standpoint, our methodology determines DE genes by taking
into account the difference in the proportion of zeros between the two treatments as
well as the difference in the average counts conditional on the gene being expressed.
This is why the CRE model detects different genes than the other methods, particularly in the MEC analysis. In Figure 2.2, we present the log2 fold change (log2FC)
against the log2 ratio of the proportion of zeros (log2PZ) for the top 500 genes determined by each method in the MEC data.
Figure 2.2 highlights the ability of our methodology to incorporate both components of the hurdle model (zero counts and expression values) when identifying
DE genes. Out of the top 500 genes identified by CRE, 433 of them had notable
differences in the number of zeros across groups as indicated by the absolute value
of the log2PZ being greater than one (i.e., one treatment group has more than twice
the number of zeros than the other). In addition, all but one of those genes also had
an absolute value of log2FC greater than one. Therefore, most of the top DE genes
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identified by CRE were not only different in terms of the number of zeros between
the stem and fibroblast cells, but also in terms of the expression values between the
treatment groups.
The other methods did not detect as many DE genes with notable differences
in the proportion of zeros between treatments. Out of all of the methods, MAST
detected the fewest number of genes with an absolute value of log2PZ greater than
one. This showcases the superiority of our model in the MEC analysis since MAST
also takes into account the differences in the proportion of zeros when determining
DE genes. Only 238 out of the top 500 genes identified by MAST had more than a
twofold difference in the proportion of zeros between treatments, whereas DESeq2,
edgeR, and SCDE identified 342, 331, and 290 genes that satisfied this criterion,
respectively.
Lastly, to demonstrate the role of the random effects in our methodology, we
ran an additional analysis of the MEC data with a model matrix that only included
the treatment group indicator covariate. This produced an estimate of ωi that is free
from potential feedback from the CDR covariate. We see from Figure 2.3A that the
estimates of the random effects within the same treatment subpopulation tend to have
similar values when CDR was not included in the model matrix. The estimated within
subpopulation variance was 0.40 while the between subpopulation variance was 14.13.
A majority of the random effect estimates for Subpopulation 1 in the stem cells and
Subpopulation 1 in the fibroblast cells were negative, whereas the estimates of the
random effects for the other subpopulations were mostly positive. When CDR was
included in the model (Figure 2.3B), there appeared to be less separation between
cluster/subpopulation means, as this information is now accounted for through CDR.
For these estimates, the within subpopulation variance was 0.91 and the between
subpopulation variance was 2.84.
In Figures 2.3C and 2.3D, the normalized random effects were plotted against
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the normalized CDR to display the relationship between these two terms. With CDR
not included in the model matrix, the random effect estimates tended to be fairly
similar to their corresponding CDR counterparts. The linear association between
these terms suggests that they are able to capture similar cellular variability. When
CDR was included in the model, there is no longer a discernible trend between the
random effects and CDR, indicating that the random effects terms are accounting for
some secondary source of cellular variation beyond the fraction of genes expressed.

2.5 Discussion
In this manuscript, we have introduced a mixed effects hurdle model for detecting
genes that are DE between treatment groups of cells in discrete scRNA-seq data. The
hurdle model structure handles the abundance of zero counts typical of scRNA-seq,
while the CRE help account for the cell-to-cell heterogeneity that has been frequently
observed within treatment groups of cells. One may also choose to use our proposed
hurdle model with independent random effects for situations where clustering may not
be suitable. Both of our proposed models (CRE and IRE) outperformed two methods
developed for detecting DE genes in scRNA-seq data (MAST and SCDE) and two
methods designed for bulk RNA-seq data (edgeR and DESeq2) in the simulation
studies. We recommend using CRE over IRE when possible as it tends to have lower
FDRs.
Our proposed methodology is comparable in structure to that of MAST, developed by Finak et al. (2015), which is also a hurdle model but for continuous data.
We likewise incorporate the covariate of CDR (Equation (2.5)) into our model matrix
to help control for the expression differences due to unwanted sources of variation.
Nevertheless, our methodology is unique because it (1) analyzes discrete count data
rather than continuous data that has already been transformed, (2) incorporates a
novel correlated random effect structure to capture additional sources of variation, and
25

(3) utilizes a Bayesian approach to parameter estimation. These three key differences
lead to the detection of more DE genes and higher TPRs and AUCs than MAST, as
illustrated in the simulation studies. The MEC data analysis also demonstrates that
our model can be more sensitive when detecting differences in the proportion of zeros. Therefore, despite the similarities in motivation, our methodology demonstrates
superior performance over MAST.
We additionally note that we utilize a VI technique to quickly obtain samples of
parameter estimates from an approximate posterior distribution rather than a typical
MCMC sampling on the true posterior. However, there has been discussion in the
literature regarding the accuracy of variance estimates under mean-field variational
Bayes. Recently, Wang and Blei (2019) show that VI can recover the diagonal of
the concentration (inverse covariance) matrix, but since the off-diagonal elements of
concentration are set to zero, the marginal variances may be underestimated.
For this reason, some have argued that mean-field variation inference may
not produce appropriate testing conclusions (e.g., Kucukelbir et al., 2017). Alternative approaches include running full MCMC or estimating parameter variances by
bootstrapping treatment assignments (Chen et al., 2018), although both would be
enormously computationally expensive. However, based on our empirical work in
Section 2.4, we emphasize that we are able to accurately estimate the regression parameters in this context and that our hypothesis tests maintain the required FDR and
achieve higher power than the competing scRNA methods. Thus, we conclude that
our proposed methodology for detecting DE genes from single-cell RNA represents a
new and powerful strategy for this biologically important problem.

2.5.1 Software Availability
The R package that implements our proposed methodology is maintained at
github.com/mnsekula/scREhurdle.
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2.6 Tables and Figures
Hurdle model: Equal clusters (N = 100)
FPR
0.010
0.009
0.010
0.010
0.011
0.019
0.007
0.094
0.058
0.073

FDR
0.046
0.045
0.046
0.047
0.050
0.086
0.038
0.200
0.321
0.377

CRE, SC3
CRE, NN=3
CRE, NN=7
CRE, TRUE
IRE
NRE
MAST
SCDE
DESeq2
edgeR

Hurdle model: Unequal clusters (N = 100)

Hurdle model: Unequal clusters (N = 1000)

CRE, SC3
CRE, NN=3
CRE, NN=7
CRE, TRUE
IRE
NRE
MAST
SCDE
DESeq2
edgeR

TPR
0.681
0.680
0.681
0.681
0.684
0.669
0.587
0.165
0.411
0.407

FPR
0.010
0.010
0.010
0.010
0.011
0.023
0.007
0.130
0.074
0.087

DE Genes
1550
1547
1550
1549
1560
1616
1320
1353
1442
1525

TPR
0.572
0.573
0.573
0.573
0.579
0.573
0.468
0.364
0.378
0.439

FPR
0.017
0.018
0.018
0.017
0.026
0.050
0.007
0.343
0.151
0.214

CRE, SC3
CRE, NN=3
IRE
NRE
MAST
SCDE
DESeq2
edgeR

TPR
0.475
0.475
0.501
0.404
0.220
0.254
0.601
0.740

FPR
0.006
0.006
0.008
0.007
0.002
0.002
0.042
0.076

DE Genes
576
576
615
497
274
303
892
1219

TPR
0.434
0.434
0.434
0.373
0.287
0.287
0.450
0.563

FPR
0.004
0.004
0.004
0.003
0.003
0.001
0.019
0.062

FDR
0.049
0.049
0.049
0.049
0.051
0.097
0.038
0.257
0.361
0.406

AUC
0.958
0.959
0.958
0.958
0.958
0.947
0.948
0.646
0.777
0.764
AUC
0.957
0.957
0.957
0.957
0.957
0.945
0.947
0.631
0.766
0.754

DE Genes
1548
1547
1550
1551
1564
1591
1337
974
1304
1400

Hurdle model: Equal clusters (N = 1000)

TPR
0.682
0.682
0.682
0.682
0.686
0.669
0.594
0.126
0.402
0.396

TPR
0.751
0.752
0.751
0.752
0.754
0.745
0.693
0.308
0.426
0.488

FPR
0.016
0.015
0.015
0.016
0.026
0.047
0.008
0.280
0.084
0.148

Splat (N = 100)
FDR
0.051
0.052
0.063
0.063
0.032
0.028
0.215
0.297

AUC
0.924
0.923
0.923
0.910
0.879
0.917
0.887
0.911

FDR
0.056
0.058
0.058
0.059
0.078
0.168
0.039
0.396
0.394
0.504
FDR
0.074
0.077
0.079
0.076
0.097
0.209
0.048
0.554
0.549
0.607

AUC
0.965
0.966
0.965
0.965
0.960
0.942
0.962
0.601
0.767
0.740
AUC
0.924
0.923
0.923
0.924
0.919
0.894
0.914
0.545
0.684
0.667

DE Genes
1746
1739
1741
1749
1830
1965
1563
2756
1549
2161
DE Genes
1367
1372
1374
1365
1444
1610
1066
3340
1941
2543

Splat (N = 1000)
FDR
0.041
0.041
0.041
0.031
0.037
0.010
0.149
0.317

AUC
0.840
0.841
0.841
0.828
0.795
0.826
0.814
0.818

DE Genes
539
540
540
459
355
294
634
987

Table 2.1: Results of performance measures from simulation studies. The subpopulation structure for the CRE model was input using either SC3, SNN-Cliq with 3 nearest
neighbors (NN=3), 7 nearest neighbors (NN=7), or the true simulated subpopulation
assignment (TRUE).

MEC data
HMEC data

CRE
38.4
77.6

IRE
40.1
69.7

MAST
1.2
2.3

SCDE
23.6
107.9

DESeq2
0.8
392.8

edgeR
0.1
0.9

Table 2.2: Running times (in minutes) of each method for each case study.
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Figure 2.1: UpSet plots of DE genes as determined by five different methods for both
the MEC and HMEC datasets. Numbers in parentheses represent the total number
of DE genes identified by the corresponding method. This figure appears in color in
the electronic version of this article.
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Figure 2.2: Scatterplots of the log2 proportion of zeros ratio (log2PZ) on the x-axis
and the log2 fold change (log2FC) on the y-axis for the top 500 most DE genes in
the MEC dataset as determined by the five different methods for detecting DE genes.
Ratios compare stem cells to fibroblast cells and the labels in each section of the plot
represent the number of genes in that section. This figure appears in color in the
electronic version of this article.
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Figure 2.3: Random effect estimates, ωbi , for the cells in the MEC dataset with points
colored according to cluster assignments determined by SNN-Cliq. (A, B) Plots of
normalized ωbi estimates by subpopulation kt (i) where t = 0 for stem cells (represented
by triangles) and t = 1 for fibroblast cells (represented by circles). (C, D) Plots of
normalized ωbi estimates vs. normalized CDR. This figure appears in color in the
electronic version of this article, and color refers to that version.
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CHAPTER 3
A SPARSE BAYESIAN FACTOR MODEL FOR THE
CONSTRUCTION OF GENE CO-EXPRESSION NETWORKS
FROM SINGLE-CELL RNA SEQUENCING COUNT DATA

3.1 Background
Deriving co-expression networks from gene expression data is a primary goal in numerous biological studies. These networks, which are commonly referred to as gene
co-expression networks (GCNs), are constructed by identifying pairs of genes that
have significant associations between their expression profiles across samples. Genes
are represented by nodes in GCNs and co-expression values are represented by edges
that connect pairs of nodes. These edges are undirected to indicate the relationships
or dependencies between genes, not the underlying cause of these associations. This
makes GCNs different from gene regulatory networks, which have directed edges to
infer casual relationships (De Smet and Marchal, 2010). As demonstrated in Eisen
et al. (1998), genes with similar expression patterns tend to be involved in similar
cellular processes and functions. Therefore, researchers are able to identify novel interactions and relationships between genes by exploring GCNs (Wolfe et al., 2005;
Wang et al., 2016).
Many of the statistical methods for building GCNs have been developed for
analyzing data consisting of expression values averaged over bulk populations of cells,
such as microarray or bulk RNA sequencing; however, advancements in technology
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now allow researchers to obtain expressions at the level of a single cell. By gathering
information from individual cells, new opportunities to study cellular heterogeneity
are presented. This is of particular interest in GCNs since mapping gene expressions
across different states of cells can lead to a better understanding of the biological
mechanisms behind this heterogeneity (Fiers et al., 2018). Single-cell RNA sequencing
(scRNA-seq) provides new and exciting opportunities to examine biological processes
at a high resolution, yet at the same time, this data presents new statistical and computational challenges (e.g., zero-inflation, high cell-to-cell variability, multimodality)
that have not been previously faced with bulk sample data (Bacher and Kendziorski,
2016). Therefore, network algorithms initially developed for bulk samples are often
not suitable for single cell analysis (Blencowe et al., 2019).
Some algorithms for network analysis in scRNA-seq data have been recently
proposed, but these methods fail to outperform general methods developed for bulk
sample data Chen and Mar (2018). To that end, we present a sparse hierarchical
Bayesian factor model to explore the network structure associated with genes. The
latent factors in our model adjust the gene expressions for each cell to help accommodate for the zero-inflated and overdispersed attributes of scRNA-seq data, and a
GCN structure is constructed by examining the shared factors between pairs of genes.
This manuscript is organized as follows. We define our proposed model and
GCN inference in Section 3.2. In Section 3.3, we apply our method to both simulated
and real data and also compare the performance of our methodology to the performance of other network methods. Finally, we conclude with a brief summary in the
Section 3.4.
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3.2 Methods
3.2.1 Hierarchical Bayesian Factor Model
Let Ygi be the (count) expression for gene g (g = 1, . . . , G) in cell i (i = 1, . . . , N ).
We assume each expression comes from the Poisson(µgi ) distribution, where the mean
µgi is modeled through the representation
F
Y

o
φf
α
µgi = βg
exp − |αgf | λif gf .
2
f =1
n

(3.1)

Here, the parameter βg denotes the average expression for gene g. For each cell i,
there are F associated factors λi = {λi1 , . . . , λiF } that impact the expression. These
factors are strictly positive and come from a Lognormal(0, φf ) distribution. We can
think of each factor as representing a distinct attribute (e.g., cell stage, pseudotime
point) that will only influence a specific set of related gene expressions. The exponent
of the f th factor λif is αgf ∈ {−1, 0, 1}, and by using this set of discrete exponents for
the factors, the expression for gene g is impacted only by the factors with αgf = −1
or 1. The adjustment term of exp{−

φf
|αgf |}
2

is included in Equation (3.1) to ensure

that E(Ygi ) is equal to βg (after marginalizing out λi ) regardless of the αgf values.
Our defined factor structure provides the flexibility required to account for the
typical cell-to-cell variability of scRNA-seq data. For a given f , λif is unique to each
cell and is only activated for a particular gene when αgf 6= 0. If the activated factors
α

λif gf for a given gene are much smaller than 1 (near zero), then µgi will be very small
and account for the high proportion of zeros typical of this data. Conversely, very large
values of the factors will increase µgi (relative to the baseline βg ) and accommodate the
occasional extremely large count. We note here that Ygi follows a Poisson distribution
conditional on the λi terms. However, the variance of Ygi , marginal on λi , is equal

to βg + βg2 exp{−φf |αgf |} − 1 . Thus, Ygi is conditionally Poisson but marginally
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overdispersed. So, despite the choice of Poisson for the distribution of the count, our
model is able to capture the high proportion of zeros and large variance typical of
scRNA data.
To finish specification of our Bayesian model, prior distributions for the remaining parameters must be defined. We use a conditionally conjugate, non-informative
prior for the average expression of gene g, βg ∼ Gamma(0.001, 0.001). The hierarchical prior structure for the scale parameter of the factors is φf ∼ Lognormal(h1 , h2 ),
where h1 ∼ N ormal(0, 100) and h2 ∼ Inverse Gamma(1, 1). For the exponent parameters, the prior is |αgf | ∼ Bernoulli(θf ) with θf ∼ Beta(1, 1). Here, we define
P (αgf = 1) = P (αgf = −1) =

θf
.
2

Consequently, P (αgf = 0) = 1−θf . The number of

associated factors F is often unknown, but one can fit multiple models with different
numbers of factors and choose the most suitable model based on a comparison of a
model selection statistic such as the Deviance Information Criterion (DIC) described
in Gelman et al. (2004). Throughout the manuscript, we will refer to our hierarchical
Bayesian factor model as HBFM.

3.2.2 Network Structure
Posterior samples for model parameters are obtained with the Markov chain Monte
Carlo (MCMC) algorithm defined later in Section 3.2.3. At each iteration of the
MCMC, a correlation matrix is computed based on the current set of parameters, and
we infer a GCN by examining the posterior distribution of this correlation matrix.
Under our proposed model, the sparse α = {αgf }(g,f ) matrix imposes a crude network
structure on the gene expressions. Consider two genes g and g 0 , where g 6= g 0 . If
αgf αg0 f 6= 0 for some f , the expressions Ygi and Yg0 i are both impacted by the shared
factor λif . Conversely, if genes g and g 0 have no shared factors (αgf αg0 f = 0 for all
f ), these genes are conditionally independent. To quantify the association between
gene g and gene g 0 , we examine the correlation (after marginalizing out λi ) between
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the values of log(µgi ) and log(µg0 i ).
We motivate our decision to use this specific correlation structure by considering the matrix Ã = ααT . The (g, g 0 ) element of this G × G matrix provides of
a summation of the associated factors that are active in both genes g and g 0 since
P
ãg,g0 = Ff=1 αgf αg0 f . When ãg,g0 > 0, the two genes have more factors with the same
association (i.e., αgf = αg0 f = 1 or αgf = αg0 f = −1) than factors with opposite
associations (i.e., αgf = 1 and αg0 f = −1 or vice versa). Conversely, when ãg,g0 < 0,
the genes have more factors with opposite associations than factors with the same
association. If ãg,g0 = 0, then either no factors are in common between the genes or
the number of factors with the same association is equal to the number of factors
with opposite associations for those genes.
By recognizing that factors with a larger variance φf will have a greater influence on the joint expression, we can weigh the shared factors by their variance. In
fact, this weighted expression is exactly equal to the the covariance (marginally over
λi ) between log(µgi ) and log(µg0 i ),
F

 X
0
Cov log(µgi ), log(µg i ) =
φf αgf αg0 f .
f =1

The active factors also increase the variance for log(µgi ),
F
 X
2
V ar log(µgi ) =
φf αgf
,



f =1

which is important when addressing the zeros and overdispersion of scRNA-seq data.
From these covariance and variance expressions, the correlation between log(µgi ) and
log(µg0 i ) is defined as
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PF


Corr log(µgi ), log(µg0 i ) = ρgg0 = r
P

f =1

F
f =1

φf αgf αg0 f
 P

2
φf αgf

F
f =1

φf αg20 f

.

(3.2)

We illustrate the mechanics of this correlation structure by considering just one
factor f . If gene g and gene g 0 have the same association with this given factor, the
correlation between log(µgi ) and log(µg0 i ) is 1. When gene g has a positive association
with factor f and gene g 0 has a negative association with factor f , the correlation
is −1. Additionally, if factor f is inactive for either of the genes, the correlation is
0. The significance of each correlation is determined by analyzing the the credible
interval (CI) of ρgg0 in the posterior distribution, as described in Section 3.2.4.
We note that each gene must have at least one active factor for our correlation


structure in Equation (3.2) to be defined since V ar log(µgi ) is equal to 0 if all of
the factors are inactive. Utilizing the correlation structure (after marginalizing out
λi ) between Ygi and Yg0 i would avoid this issue, but the additional βg term in the
variance leads to a correlation structure dependent on the average expression for each
gene. For this reason, we do not focus on the correlation structure between Ygi and
Yg0 i . Throughout, if (3.2) is 00 , we define this correlation as zero to match the zero
value for Corr(Ygi , Yg0 i ).
3.2.3 Model Inference
The posterior distribution for our hierarchical Bayesian model is complex, and so
MCMC is required for inference. For simplicity in our posterior distribution notations,
 φ0
Q
α f0
let ψgif = f 0 6=f exp − 2f |αgf 0 | λif 0g . We utilize an MCMC sampler that iterates
through the following steps:
1. For g = 1, . . . , G, update
βg ∼ Gamma 0.001 +

PN

i=1

ygi , 0.001 +
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PN QF
i=1

f =1


exp −

φf
|αgf |
2

α f

λif g


.

2. For f = 1, . . . , F , update θf ∼ Beta 1 +

PG

g=1 |αgf |

, 1+G−

PG



g=1 |αgf |

.

3. For all g, f , sample αgf from a multinomial distribution with
p(αgf = 0| · · · ) =

A
,
A+B+C

p(αgf = 1| · · · ) =

B
,
A+B+C

p(αgf = −1| · · · ) =

C
.
A+B+C

Here, A, B, and C are defined as

P
A = (1 − θf )exp − βg N
i=1 ψgif ,
B=


θf 
exp
2

C=


θf 
exp
2

− βg

PN

− βg

PN

i=1


exp −

exp{−
i=1
λif

φf
2

}

φf
2

λif ψgif ,

ψgif .

1/h2
∗
4. Update h1 ∼ N ormal( 1/100+F/h
2

PF

f =1

5. Update h2 ∼ Inverse Gamma( F2 + 1,

log(φf ), (1/100 + F/h2 )−1 ).

PF

2
f =1 (log(φf )−h1 )

2

+ 1).

6. For f = 1, . . . , F , use a Metropolis-Hastings step to update φf . The posterior
distribution for φf is
−1
−N
2

n  P P
PN
2
φ
N
i=1 log(λif )
exp − 2f G
|α
|y
+
+
g=1
i=1 gf gi
2φf
o
 φf
PN
PG
αg f
(log(φf )−h1 )2
λ
ψ
.
β
exp
−
+
|α
|
gif
gf
i=1 if
g=1 g
2h2
2

p(φf | · · · ) ∝ φf

(c)

We propose a candidate value for φf

through a pseudo-random walk from

Lognormal(φf , σ 2 ) and accept this value with the usual Metropolis-Hastings
P
ratio. If factor f is not active for any gene (i.e., G
g=1 |αgf | = 0), then update
φf from the Lognormal(h1 , h2 ) prior.
7. For all i, f , use a Metropolis-Hastings step to update λif . By defining
κ=

PG

g=1

ygi αgf ,
φf
2

τ =2

PG


I(αgf = 1)βg exp −

χ=2

PG


I(αgf = −1)βg exp −

g=1

g=1

ψgif ,
φf
2
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ψgif ,

where I(·) represents an indicator variable, the posterior distribution for λif is

o
n
log(λif )2
χ
κ−1
1
.
p(λif | · · · ) ∝ λif exp − 2 τ λif + λif + φf
This posterior has a similar appearance to a generalized inverse Gaussian (GIG)
log(λif )2 
distribution with an extra exponential term
. To that end, we propose
φf
(c)

a candidate value for λif from GIG(κ, bτ, bχ), where the multiplicative factor
of b on τ and χ is used to create thicker tails in the proposal distribution. For
our sampling scheme, we set b to 0.9. Acceptance of the candidate value is
determined by the typical Metropolis-Hastings rules. If τ = χ = 0, factor f is
not active and we update λif from the Lognormal(0, φf ) prior.
Due to the large number of model parameters and complexity of the posterior
distribution, it is possible for the MCMC sampler to get stuck exploring a local
mode of the posterior rather than exploring the entire posterior distribution. This
is particularly an issue with the one-at-a-time sampling for α, which does not allow
for large scale moves such as splitting or combining factors. To address this sampling
problem, we implement a stochastic EM approach (Celeux et al., 1996; Bhattacharya
and Dunson, 2011) to obtain initial values for our MCMC algorithm.
For the stochastic EM approach, we run the usual MCMC sampler but replace
sampling with optimization in several of the steps. Specifically, we optimize the
following steps of the sampler:
1. For g = 1, . . . , G, update βg to its conditional posterior mode.
3. For all g, f , select the value of αgf with the highest probability: p(αgf = 0| · · · ),
p(αgf = 1| · · · ), or p(αgf = −1| · · · ).
6. For f = 1, . . . , F , find φf that optimizes its respective conditional posterior distribution. In this step, we utilize the optimize function from the base packages
in R (R Core Team, 2018).
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After randomly selecting starting values and running an initial MCMC sampling warm-up period, the stochastic EM approach is implemented for a number of
iterations (e.g., 2000 iterations) to ensure stabilization. Parameter estimates are then
calculated by averaging the samples generated from a final set of iterations (e.g., the
samples from the last 200 iterations). In the case of the discrete αgf parameters, we
select the value (either −1, 0, or 1) that has the highest frequency. The parameter
estimates from this stochastic EM approach are then input as the initial starting values of our MCMC sampler. We choose to run a number of MCMC chains (in parallel)
and implement the stochastic EM approach individually for each chain to produce
different initial starting values. For final parameter inference, the lowest performing chains (i.e., the chains with the lowest marginal likelihoods) are discarded from
analysis.

3.2.4 Network Inference
The association level network structure Ñ = {ñgg0 }(g,g0 ) between genes is obtained
by analyzing the posterior of the correlation matrix defined in Equation (3.2). For
each (g, g 0 ) element in the correlation matrix, M samples are used to calculate the
PM
(m)
posterior mean ρbgg0 = M1
m=1 ρgg 0 . This estimate provides a quantifiable value of
association between genes g and g 0 .
Since we are working in the Bayesian paradigm, we can examine the CI of the
posterior to determine whether or not genes g and g 0 are associated with one another.
By choosing an appropriate level of significance α∗ , two genes have a significant
association when zero is excluded from the 100(1 − α∗ )% CI. A second method to
determine significant associations from the posterior samples of ρgg0 is to find the
smallest 100(1 − a∗ )% CI that includes 0. The corresponding a∗ value would indicate
the proportion of the posterior distribution outside of the smallest CI that includes
0. Hence, we can think of a∗ as an approximate “p-value” that can be used to rank
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correlations by significance.

3.3 Results
3.3.1 Datasets
To demonstrate the feasibility of our methodology, we generated simulated datasets
consistent with our proposed methodology structure. Each Ygi count was sampled
from Poisson(µgi ), with µgi modeled from Equation (3.1). The βg parameters were
randomly sampled from Gamma(3,0.5) and the λif parameters were randomly sampled from Lognormal(0, φf ).
For the network structures, we fixed the values of the α matrix. In each
dataset, we considered G = 50 genes and sorted them into ten groups of five (e.g.,
Group 1 consisted of genes 1 - 5, Group 2 consisted of genes 6 - 10), and all genes
within each factor group were assigned the same αgf values. In three of the datasets,
we considered the same network structure (Figure 3.1A) consisting of 350 “true”
edges using Fsim = 10 factors and varied the number of cells to be either N = 125
(Sim 1), N = 500 (Sim 3), or N = 1, 000 (Sim 5). In the other three datasets, we
utilized a network structure of Fsim = 15 factors to simulate expression values, which
created a network structure with 425 “true” edges (Figure 3.1C). Again, the number
of cells were set to either N = 125 (Sim 2), N = 500 (Sim 4), or N = 1, 000 (Sim
6). In order to define the correlation structures, the values of φf were fixed to be
either 0.2, 0.35, 0.5, 0.65, or 0.8. In the simulations with Fsim = 10, each fixed value
of φf was used twice (e.g., φ1 = φ2 = 0.2, φ3 = φ4 = 0.35) and in the simulation
with Fsim = 15, each fixed value was used three times (e.g., φ1 = φ2 = φ11 = 0.2,
φ3 = φ4 = φ12 = 0.35).
We also ran analyses on two real datasets to demonstrate the utility of our
method on real data. The expression counts for the mouse brain single-cell (MBSC)
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dataset from Zeisel et al. (2015) were downloaded from the Gene Expression Omnibus
(GEO) database under accession number GSE60361. For this analysis, we selected the
G = 48 known and novel genetic markers displayed in Figure S6 of the supplementary
materials of Zeisel et al. (2015) and cells with a library size of zero were removed,
leaving a total of N = 2, 946 cells in the dataset. The second dataset was obtained
from the GEO database under accession number GSE90975 and contains the gene
expressions from single-cell analysis of neurodegeneration in microglia cells of mice
(Tay et al., 2018). We considered all N = 944 cells and analyzed the G = 101
differentially expressed genes from Figure S1 of Tay et al. (2018). This second real
dataset is referred to as the mouse microglia cell (MMC) data.

3.3.2 Simulation Studies
Using the simulated data, we fit our proposed model (HBFM) by running the MCMC
sampling algorithm described in Section 3.2.3. The stochastic EM approach was run
for 2, 000 iterations, after an initial warm-up period of 100 iterations, and samples
from the last 200 iterations of this approach were used to obtain starting parameter
values for the MCMC sampler. We ran the MCMC sampler for 4, 000 iterations and
used the last 1, 000 iterations for inference.
Nine runs of HBFM were considered by selecting nine different choices for the
number of factors: F = 5, 8, 10, 12, 15, 18, 20, 22, and 25. For each choice of F ,
we ran eight separate MCMC sampling chains in R (R Core Team, 2018), and used
only the samples from the five chains with the highest average marginal likelihood
for inference. DIC was calculated using half the posterior variance of the deviance to
estimate the effective number of parameters Gelman et al. (2004), and the number
of factors F with the lowest DIC was selected as the “best” model choice. In the
cases where F = 25 was chosen as the “best” model, we ran an additional model
with F = 28 factors to ensure that the upper bound of our considered set was also
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the optimal choice for the number of factors. For each pair of genes g and g 0 in the
“best” model, we tested for a significant relationship by using a 95% CI for ρgg0 .
To evaluate the performance of our model against other gene network methods,
we ran the single-cell co-expression model LEAP (Specht and Li, 2016) and the singlecell regulatory network models of PIDC (Chan et al., 2017) and SCODE (Matsumoto
et al., 2017) on the simulated data. After creating a symmetric correlation matrix
with the LEAP package in R, a permutation analysis was then performed with this
package using a false discovery rate (FDR) of 5% to determine a cutoff for significant
correlation values. PIDC was implemented in Julia (Bezanson et al., 2017) using the
basic usage code available at https://github.com/Tchanders/NetworkInference.jl. For
SCODE, we ran the R code available at https://github.com/hmatsu1226/SCODE and
averaged the results of 50 separate trials using the same parameters as the example
code provided on the GitHub page. The methods of LEAP and SCODE utilize a
pseudotime estimation of the cells and the R package monocle (Trapnell et al., 2014)
was used for this estimation.
We also included three popular network methods originally developed for bulk
data in our simulation studies: partial correlation, Bayesian networks, and GENIE3
(Huynh-Thu et al., 2010). Partial correlation (PCORR) was implemented with the
R package ppcor (Kim, 2015) using the Spearman partial correlation coefficient. We
performed the Benjamini-Hochberg (Benjamini and Hochberg, 1995) procedure to
control for FDR and defined 5% as the threshold for significant correlation values.
Bayesian networks (BN) were constructed in R with the bnlearn package (Scutari,
2010). After learning a set of 1,000 bootstrap replicates with the hill-climbing algorithm, the optimal network was created using model averaging (Scutari, 2010). The
analysis for GENIE3 was performed in R with the GENIE3 package using default
parameters.
The methods of PIDC, SCODE, and GENIE3 output a matrix of scores/weights
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to indicate how likely each gene-gene regulatory link is, but these methods do not
determine a cutoff score/weight for identifying significant associations. To be consistent across the simulated datasets, we chose the threshold for PIDC, SCODE, and
GENIE3 such that the number of edges in the constructed network was equal to the
number of edges determined by our HBFM method. By matching the number of
edges to our method, we provide a direct comparison between these methods and
HBFM. In addition, SCODE and GENIE3 provide different scores/weights for the
different directions of edges in the network; therefore, we selected the directed edges
with the higher magnitude to quantify the strengths of the gene-gene associations for
these methods.
For each simulated dataset, we compared the significant gene-gene associations identified by each method to the “true” gene-gene associations created by the
simulated network structure. The measures of true positive rate (TPR), FDR, area
under the receiver operating characteristic curve (AUC), and number of significant
edges in the estimated network were used to compare methods. When calculating the
AUC, the regulatory link score/weight was used for PIDC, SCODE, and GENIE3,
the association strength was considered for BN, and for the remaining methods the
inverse of the adjusted p-value (inverse of the approximate “p-value” in HBFM) was
utilized. We note that selecting a different threshold for PIDC, SCODE, and GENIE3
may impact the TPR and FDR results since the number of edges in the constructed
network will change; however, the AUC results will remain unchanged by the threshold choice. We found that the FDRs for SCODE and GENIE3 tend to remain fairly
stable across different threshold choices, and the FDR of PIDC tends to increase
as the threshold increases. The performances of the different network methods are
summarized in Table 3.1.
From the simulation results, we see that our methodology performs quite well
across the different scenarios, as HBFM has consistently high power and low FDRs.
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The heatmaps of estimated correlation structures produced by HBFM resemble the
“true” structure of the simulated datasets (Figure 3.1). Our model outperforms the
other methods across the TPR and AUC performance measures in these simulation
studies. In Sim 6, HBFM and PIDC perform very comparably when the number
of edges is the same. While PIDC has a slightly higher TPR and lower FDR at
this threshold, HBFM does have the higher AUC. The FDR of our method is also
reasonably controlled to a nominal level, especially compared to the FDRs of LEAP,
SCODE, GENIE3, and PCORR. While BN had lower FDRs than HBFM in some of
the simulations, it also identified the fewest number of edges and had lower TPR and
AUC than HBFM.
When using DIC as the criterion for our model selection, the best-fitting model
often contains more factors than the “true” simulated structure in the examples we’ve
considered so far. However, we note that the additional factors provide more opportunities to explore different factor structures within the model during MCMC sampling.
For example, a single factor from a model with F = 10 may be split into several factors when using a model with F = 20. Therefore, it is not surprising that the “best”
model choices contain more factors than the “true” number of factors, Fsim , as these
models are more likely to explore the high regions of the posterior as they are less
likely to get stuck during sampling.

3.3.3 Case Studies
The same network methods described in Section 3.3.2 were applied to the two real
datasets. For each method, we constructed a network and obtained the top 100
most significant gene-gene pairs, out of the 1,128 possible pairs, for comparison in
the MBSC analysis and the top 500 most significant pairs, out of the 5,050 possible
pairs, for comparison in the MMC analysis (approximately the top 10% associations
for each dataset). From the nine different numbers of factors considered for HBFM,
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we selected F = 25 factors as the “best” choice for both the MBSC and MMC data
because this factor choice had the lowest DIC.
Since the “true” network structure of this real data is unknown, we constructed
three reference protein-protein interaction networks with the STRING database (Szklarczyk et al., 2014) for each dataset to compare across the different methods. These
reference networks were created by adjusting the threshold for the minimum required
interaction score between pairs of proteins: high confidence (minimum score of 0.700),
medium confidence (minimum score of 0.400), and low confidence (minimum score
of 0.150). STRING computes these scores by combining the probabilities of different
evidence sources (e.g., text mining, experiments, databases) and correcting for the
probability of observing the interactions by random chance (von Mering et al., 2005).
This is, of course, an imperfect reference as any method may detect novel interactions that have not been previously published. Likewise, some entries in STRING
may represent published false positives. However, on average, the method producing the GCN most similar to the STRING reference set should be considered as the
network most consistent with biological literature.
The UpSet plots (Lex et al., 2014) for the intersection between the the top 100
associations in the MBSC dataset and the top 500 associations in the MMC dataset
identified by each network method is displayed in Figure 3.2. Interestingly, each
method identifies a number of unique associations with only 3 and 10 associations
in common among all seven methods in the MBSC and MMC datasets, respectively.
Table 3.2 displays the comparisons of the top associations from each method to the
reference networks. We see that HBFM has the highest number of associations in
common with each STRING reference network. This is particularly apparent in the
MMC dataset, where over 80% of the top 500 genes pairs detected by our method
matched with the STRING reference sets. Less than half of the top 500 gene pairs
from the other methods overlapped with the high and medium MMC reference sets.
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When comparing with the low MMC reference set, HBFM matched 94.8% of the top
500 identified gene pairs. PIDC had the second highest overlap with the low MMC
reference set matching only 64.8% of its top 500 gene pairs. Based on these results,
our methodology is able to identify more known protein-protein interactions in these
real datasets than the other network methods.
We also evaluated our HBFM model by creating 100 posterior predictive
datasets (PPDs; Gelman et al., 2004) from each chain of the MMC analysis (500
PPDs in total) and comparing the overdispersion and proportion of zeros in these
datasets to the overdispersion and proportion of zeros in the MMC dataset. Each
count Ygi of the PPDs was generated from Poisson(µgi ), with µgi modeled from Equation (3.1) using parameter estimates (with the exception of the λi parameters) from
different iterations of the MCMC sampler. The λi values were drawn randomly from
Lognormal(0, φf ).
In Figure 3.3A, the log(variance) is plotted against the log(mean) across all
G = 101 genes for the real expressions in the MMC dataset and the estimated expressions from a single representative PPD. Both datasets display high cell-to-cell
variability, as expected of scRNA-seq data. In fact, even with the choice of Poisson
for the (conditional) distribution of the counts, the PPDs generated from the parameters estimated from the MMC dataset tend to generate variability that is comparable
to the variability observed in the real data. We can see that many genes from the
PPD are overdispersed, especially those with log(means) greater than 1, as in the true
MMC data. From Figure 3.3B, the gene expression in the MMC data is zero-inflated
as the proportion of zero values for each gene ranged between 0 and 0.99. In the PPD,
the proportion of zeros for each gene tended to be only slightly lower than what was
observed in the real dataset. Nevertheless, the proportion of zero expressions were
still quite high and variable across the genes in the PPD.
To further evaluate the PPDs generated by HBFM, we selected nine genes from
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the MMC dataset that represent the 10th through 90th percentiles of average gene
expression and examined the log(variance/mean) and proportion of zeros of these
genes across all PPDs. Figure 3.4A illustrates that across the PPDs, the estimated
log(variance/mean) for most of the genes is greater than 0, indicating variances that
are larger than their corresponding means. Also, for a majority of these genes, the
true log(variance/mean) value is captured across the PPD estimates. The estimated
proportion of zeros for these genes across the PPDs also capture the true proportion
of zeros from the MMC dataset, as displayed in Figure 3.4B.

3.4 Discussion
In this manuscript, we have presented a hierarchical Bayesian factor model (which
we have referred to as HBFM) for constructing GCNs from scRNA-seq data. The
results from our simulation studies demonstrate that HBFM is able to identify true
co-expressions while maintaining a nominal FDR across different numbers of cells
and different network structures. Our case study analyses with the MBSC and MMC
datasets also demonstrate the practical use of HBFM for determining significant genegene associations, as our model was able to detect more known protein-protein interactions than the other network methods.
The number of genes (G) in the simulated and real datasets presented in this
manuscript is smaller than what is often considered for other scRNA-seq data problems, such as clustering cells/genes and detection of differentially expressed genes.
However, the use of a smaller pre-screened set of genes is common among other complex network methods (Fiers et al., 2018; Delgado and Gómez-Vela, 2018). In part,
this is due to the GCN being determined by G ∗ (G − 1)/2 correlations, a quadratic
number of parameters, making it difficult to numerically and graphically communicate results for large G. While constructing a GCN as an exploratory analysis from an
entire dataset is possible with our method, it may not be computationally practical.
47

HBFM performs Bayesian inference via iterative MCMC, which can become computationally expensive as the number of genes (G) and number of cells (N ) increase.
In light of these computational considerations, we typically recommend the user consider some initial analysis such as clustering or differential expression to determine a
smaller set of genes, generally 100 or fewer, before using HBFM to estimate the GCN.
On a system with an Intel Core i7 processor (3.5 GHz) and 8 GB of RAM, the running
time for a single chain of HBFM with F = 25 factors was 32.7 hours for the MBSC
data (G = 48, N = 2, 946) and 22.1 hours for the MMC data (G = 101, N = 944).
In our methodology, the distribution of count values is defined to follow a
Poisson distribution, conditional on the latent factors λi . While we acknowledge
that the Negative Binomial distribution tends to be the preferred choice for modeling
overdispersed data, the latent factors of HBFM are random effects that help account
for the additional variability across samples. After marginalizing out λi , E(Ygi ) = βg

and V ar(Ygi ) = βg + βg2 exp{−φf |αgf |} − 1 . As illustrated in the PPDs generated
from the real MMC data, HBFM is able to generate overdispersed and zero-inflated
data that is consistent with the features of the real data. Hence, the use of a Poisson
distribution is not a meaningful drawback.
We also note that the high resolution of scRNA-seq technology allows researchers the opportunity to estimate “pseudotime” and obtain a temporal ordering
of cells (Trapnell et al., 2014; Street et al., 2018). The general idea is that at any
given time, a cell population will consist of cells that are at different stages of their
cell cycles, and cells in different stages will express different sets of genes. Our method
does not directly take pseudotime into account, but the latent factors (λi ’s) are likely
to adapt and capture this contribution on the gene expression.
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3.4.1 Software Availability
The source code for implementing the HBFM model is available as an R package at
https://github.com/mnsekula/hbfm.
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3.5 Tables and Figures

Sim 1: N=125, Fsim =10
HBFM, F = 15
LEAP
PIDC
SCODE
BN
GENIE3
PCORR

TPR
0.760
0.386
0.634
0.229
0.206
0.540
0.123

FDR
0.153
0.378
0.293
0.745
0.077
0.398
0.566

AUC
0.927
0.705
0.821
0.550
0.682
0.746
0.599

Edges
314
217
314∗
314∗
78
314∗
99

Sim 2: N=125, Fsim =15
HBFM, F = 15
LEAP
PIDC
SCODE
BN
GENIE3
PCORR

Sim 3: N=500, Fsim =10
HBFM, F = 25
LEAP
PIDC
SCODE
BN
GENIE3
PCORR

TPR
0.889
0.743
0.794
0.246
0.277
0.554
0.300

FDR
0.034
0.608
0.137
0.733
0.040
0.398
0.266

AUC
0.984
0.741
0.915
0.503
0.751
0.754
0.683

Edges
322
664
322∗
322∗
101
322∗
143

TPR
0.909
0.780
0.857
0.269
0.323
0.603
0.403

FDR
0.076
0.550
0.128
0.727
0.050
0.387
0.291

AUC
0.973
0.804
0.954
0.496
0.793
0.764
0.720

Edges
344
606
344∗
344∗
119
344∗
199

FDR
0.111
0.275
0.297
0.654
0.037
0.350
0.442

AUC
0.820
0.665
0.742
0.504
0.672
0.711
0.602

Edges
306
200
306∗
306∗
82
306∗
113

Sim 4: N=500, Fsim =15
HBFM, F = 25
LEAP
PIDC
SCODE
BN
GENIE3
PCORR

Sim 5: N=1000, Fsim =10
HBFM, F = 20
LEAP
PIDC
SCODE
BN
GENIE3
PCORR

TPR
0.640
0.341
0.506
0.249
0.186
0.468
0.148

TPR
0.704
0.402
0.621
0.226
0.212
0.466
0.261

FDR
0.029
0.305
0.143
0.688
0.032
0.357
0.327

AUC
0.929
0.696
0.866
0.575
0.716
0.729
0.624

Edges
308
246
308∗
308∗
93
308∗
165

Sim 6: N=1000, Fsim =15
HBFM, F = 25
LEAP
PIDC
SCODE
BN
GENIE3
PCORR
∗

TPR
0.624
0.591
0.633
0.221
0.247
0.440
0.294

FDR
0.070
0.541
0.056
0.670
0.037
0.344
0.251

AUC
0.904
0.680
0.889
0.510
0.710
0.700
0.669

Edges
285
547
285∗
285∗
109
285∗
167

Number of edges fixed to match HBFM.

Table 3.1: Results from simulation studies. The value of F for HBFM represents the
number of factors in the “best” model choice, as determined by DIC.
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HBFM, F=25
LEAP
PIDC
SCODE
BN
GENIE3
PCORR
Reference total

MBSC reference set
High Medium Low
10
23
39
9
20
34
7
17
38
5
14
31
3
16
36
4
14
37
6
15
32
42
116
322

MMC reference set
High Medium Low
416
446
474
78
121
252
151
197
324
42
75
165
162
208
319
99
142
290
116
154
236
697
897
1600

Table 3.2: The overlap between the top 100 gene-gene associations in the MBSC
dataset and the top 500 gene-gene associations in the MMC dataset for each network
method. Reference networks were created by the STRING database.
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Figure 3.1: (A) Heatmap of the “true” correlation structure in Sim 3 (F = 10, N =
500). (B) Heatmap of the estimated correlation structure in Sim 3 by HBFM and
F = 25 factors. (C) Heatmap of the “true” correlation structure in Sim 4 (F =
15, N = 500). (D) Heatmap of the estimated correlation structure in Sim 4 by
HBFM and F = 25 factors.
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Figure 3.2: (A) UpSet plot of the top 100 gene-gene associations as determined by
seven different methods for the MBSC dataset. (B) UpSet plot of the top 500 genegene associations as determined by seven different methods for the MMC dataset.
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Figure 3.3: Example comparison between the MMC dataset and one representative
PPD generated by HBFM. (A) The log(variance) vs. log(mean) scatterplot for each
gene. (B) Boxplots of gene-specific proportion of zeros.
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Figure 3.4: Properties of PPD estimates from a sample of nine genes in the MMC
dataset. Genes were selected based on percentiles (10th through 90th) of average gene
expression. (A) Violin plots of estimated log(variance/mean) for each gene across all
PPDs. (B) Violin plots of estimated gene-specific proportion of zeros across all PPDs.
The blue stars represent the true values from the MMC dataset.
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CHAPTER 4
SINGLE-CELL DIFFERENTIAL NETWORK ANALYSIS WITH
SPARSE BAYESIAN FACTOR MODELS

4.1 Introduction
Gene network modeling has become essential to the understanding of complex biological systems related to health and disease. These networks allow researchers to uncover
and interpret relationships and interactions between genes during different biological
processes (Blencowe et al., 2019). There are several popular methods for constructing gene networks from microarray and bulk RNA sequencing data (Margolin et al.,
2006; Langfelder and Horvath, 2008; Huynh-Thu et al., 2010), and more recently,
methods for identifying gene networks from single-cell RNA sequencing (scRNA-seq)
data have also been proposed (Specht and Li, 2016; Chan et al., 2017; Matsumoto
et al., 2017) including our methodology for scRNA-seq gene network inference from
Chapter 3. Interestingly, the vast majority of these methods have focused only on
analyzing gene expressions from one cellular population, such as a single tissue type,
disease, or environmental condition.
Since biological systems are highly dynamic, there is also great interest in
performing differential network analysis to examine the changes in network structure under different biological settings. In the context of bulk population data (i.e.,
microarray and bulk RNA sequencing), efforts have been made to develop different
strategies for identifying differences between gene-gene networks. Some approaches
propose qualitative analyses through visual inspection of different network topologies
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(Caldana et al., 2011; Weston et al., 2011), while others rely on statistical tests to
determine differences across conditions (Choi and Kendziorski, 2009; Gill et al., 2010;
Fukushima, 2013). For scRNA-seq data, however, there has been very little research
in developing methods to compare gene networks from two (or more) biological conditions. Wang et al. (2017) present several proof-of-concept analyses for comparing
network structures constructed from scRNA-seq data by utilizing a differential connectivity test that was originally developed by Gill et al. (2010) for microarray gene
expression data. In Chiu et al. (2018), the scRNA-seq-based differential network (scdNet) analysis method is proposed to first determine a sample size corrected gene-gene
correlation matrix for each cellular state and then identify differential gene-gene pairs
across these states. The developers of scdNet state that, to their knowledge, their
method is the first tool for differential network analysis of scRNA-seq data.
In this work, we adapt our hierarchical Bayesian factor methodology for constructing gene co-expression networks (GCNs) from scRNA-seq data to explore differences in the network structure across various cell groups due to different biological
conditions, cell types, cell stages, or other group choice. The key adjustment in this
new model is that the parameters that determine which factors are activated in a gene
are now treatment-dependent to allow for the calculation of gene-gene co-expression
within each treatment group. For simplicity, we consider a two-group setting and
refer to these groups as treatment and control, but our model can easily be extended
to a multiple group scenario, if necessary.
The rest of this manuscript is organized as follows. We define our proposed
model and inference for differential network analysis in Section 4.2. Results from
simulation studies are presented in Section 4.3 to demonstrate the performance of
our methodology. In Section 4.4, we conclude with a brief discussion on our results.
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4.2 Methods
4.2.1 Hierarchical Bayesian Factor Model for Two Treatment Groups
Let Ygi be the expression count of gene g (g = 1, . . . , G) in cell i (i = 1, . . . , N ) for
treatment t ∈ {0, 1}. We define t = 0 as the control (reference) group and t = 1 as
the treatment group. Like our model in Chapter 3, we assume that each expression
comes from the Poisson(µgi ) distribution, but here, we model the log-mean log(µgi )
through the representation

log(µgi ) = βg + ti δg +

F
X

λif αgf ;ti −

f =1

F
nX
α2

gf ;ti

f =1

2

o
.

(4.1)

For notation purposes in Equation (4.1), ti indicates the treatment group (ti ∈ {0, 1})
for cell i. Marginally over λi , the parameter βg denotes the log-mean expression for
gene g in the control group and βg + δg is the log-mean expression for gene g in the
treatment group. Hence, δg represents the log-fold change in the expression for gene
g. For each cell i, there are F associated factors λi = {λi1 , . . . , λiF } that impact the
expression. Each factor can be thought of as some unique cellular attribute (e.g., cell
stage, pseudotime point) that will only affect a specific set of related gene expressions.
Since we are defining our model on the log scale, we assume these factors come from
a Normal(0, 1) distribution.
The magnitude of the impact by factor f on gene g in treatment t is influenced
by the parameter αgf ;t ∈ R. With this setup, the expression for gene g in treatment t
is minimally impacted by factors with αgf ;t values close to 0 and greatly impacted by
factors with absolute values of αgf ;t much greater than 0. It is important to note that
the αgf ;t ’s are treatment dependent to allow factors to impact the gene expressions
differently across the treatments. Clearly if αgf ;0 and αgf ;1 have similar values, then
factor f has a similar influence on the gene expression in both treatments. However,
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the more interesting case is when αgf ;0 and αgf ;1 have very different values, which
indicates a difference in the impact of factor f on gene g between the groups. By
examining the differences between the αt = {αgf ;t }(g,f ) matrices, we can identify
differences between the gene networks of the treatment groups.
For most factors, we assume that the values of αgf ;0 and αgf ;1 in our model
will be similar. In other words, we anticipate that most factors will have a similar
impact on the genes within both groups. We also expect each factor f to impact
only a small number of genes, and so the αt matrices will be sparse. To that end, we
define the following hierarchy on the αgf ;t parameters:
αgf ;t ∼ N ormal(e
αgf , κ2gf ;t τf2 ) ,

(4.2)

κgf ;t ∼ half-Cauchy(0, 1) ,
τf ∼ half-Cauchy(0, 1) ,
α
egf ∼ N ormal(0, ζ 2 ) ,

(4.3)

ζ ∼ half-Cauchy(0, 1) .
Under this scheme, the horseshoe prior (Carvalho et al., 2009) placed on each αgf ;t
in Equation (4.2) will help shrink the values of αgf ;0 and αgf ;1 together. For a given
factor f , we define τf as the global shrinkage parameter and the κgf ;t ’s as the local
shrinkage parameters. The global shrinkage parameter will pull the values of αgf ;0
and αgf ;1 towards α
egf , while the treatment-dependent local shrinkage parameters
will allow some values to be much different than α
egf . Thus, the κgf ;t ’s can account
for any variability between the groups. Our model favors borrowing information
across treatments, so it should be efficient for factor-gene effects that are common.
Nevertheless, the horseshoe priors allow big differences to accommodate differences
between treatments.
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To achieve more sparsity, a horseshoe prior could also be placed on the α
egf
parameters in Equation (4.3) to help shrink most of these values close to 0:
2 2
α
egf ∼ N ormal(0, ωgf
ζ ),

(4.4)

ωgf ∼ half-Cauchy(0, 1) ,
ζ ∼ half-Cauchy(0, 1) .
Here, ζ is a global shrinkage parameter that will pull the values of α
egf towards 0. In
Equation (4.4), we introduce local shrinkage parameters (ωgf ’s) to allow some of the
α
egf values to be much different than 0. Therefore, the horseshoe priors on the αgf ;t
parameters (Equation (4.2)) will promote sparsity in the treatment difference and the
horseshoe priors on the α
egf parameters (Equation (4.4)) will promote sparsity in the
underlying network.
The flexibility of our defined factor structure allows for the zero-inflation and
high cell-to-cell variability of scRNA-seq data. For a given f , λif is unique to each cell
and only affects a particular gene within a treatment when αgf ;t 6= 0. If the activated
factors λif αgf ;t for a given gene are highly negative, then µgi will be very small and
account for the high proportion of zeros typical of this data. Conversely, large positive
values of the factors will increase µgi (relative to the baseline of either exp{βg } for the
control group or exp{βg + δg } for the treatment group) and accommodate extremely
 PF α2gf ;ti
is included
large counts. In Equation (4.1), the adjustment term of −
f =1
2
in our model to ensure that E(Ygi ) in the control group is equal to exp{βg } and
E(Ygi ) is equal to exp{βg + δg } for the treatment group (after marginalizing out λi )
regardless of the αgf ;t values. While we choose to let Ygi follow a Poisson distribution
conditional on the λi terms, the variance of Ygi , marginal on λi , is
F
Y


2
V ar[Ygi ] = exp{βg + ti δg } 1 + exp{βg + ti δg }
exp{αgf
}
−
1
.
;t
f =1
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(4.5)

Hence, Ygi is conditionally Poisson but marginally overdispersed.
To complete the specification of our Bayesian model, we define priors for the
average gene expression parameters as βg ∼ N ormal(0, σβ2 ) and δg ∼ N ormal(0, σδ2 ),
with standard deviation hyperparameters σβ and σδ from half-Cauchy(0, 1). Our
methodology does rely on fixed number of latent factors F , which unfortunately is
often unknown. Nevertheless, one can fit multiple models with different numbers of
factors and choose the most suitable model based on a comparison of a model selection
statistic such as the Deviance Information Criterion (DIC) described in Gelman et al.
(2004) or the Watanabe-Akaike Information Criterion (WAIC; Watanabe, 2010).

4.2.2 Network Structure and Inference
We use Hamiltonian Monte Carlo (Neal, 2011) from Stan (Stan Development Team,
2018) to generate samples from the posterior distributions for inference. At each iteration, a co-expression matrix for each treatment group is calculated based on the
current set of parameters. While the αt matrices in our model do impose a crude
network structure on the gene expressions for each treatment, the individual αgf ;t
parameters are non-identifiable, and so we cannot perform inference about these parameters directly. To that end, we consider the matrices At = αt αTt whose elements
are identifiable.
For a given treatment t, the (g, g 0 ) element, where g 6= g 0 , of the G × G matrix
At provides a summation of impact by the associated factors that are active in both
P
genes g and g 0 since At(g,g0 ) = Ff=1 αgf ;t αg0 f ;t . This expression also happens to be
equal to the covariance (after marginalizing out λi ) between the values of log(µgi )
and log(µg0 i ) in treatment t,
F

 X
Cov log(µgi ), log(µg0 i ) =
αgf ;t αg0 f ;t .
f =1

With the marginal variance for log(µgi ) being
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F

 X
2
V ar log(µgi ) =
αgf
;t ,
f =1

the correlation between log(µgi ) and log(µg0 i ) is defined as
PF


Corr log(µgi ), log(µg0 i ) = ρgg0 ;t = r
P

F
f =1

f =1

αgf ;t αg0 f ;t
 P

2
αgf
;t

F
f =1

αg20 f ;t

.

(4.6)

We focus our interest on the marginal correlation of the log-means due to the simplistic
nature of the correlation structure and its reliance on only the αgf ;t parameters. As
displayed in Equation (4.5), the variance expression of Ygi includes a set of βg and
δg parameters that cannot be factored out, which means the correlation structure
between Ygi and Yg0 i will depend on the average expression for each gene in each
treatment. For this reason, we do not utilize the correlation structure between Ygi
and Yg0 i .
The gene-gene network structure Ñt = {ñgg0 ;t }(g,g0 ) within each treatment
group is obtained by analyzing the posterior of the correlation matrix defined in
Equation (4.6). To provide a quantifiable value of association between genes g and g 0
within treatment t, M samples of each (g, g 0 ) element in the correlation matrix are
PM
(m)
used to calculate the posterior mean ρbgg0 ;t = M1
m=1 ρgg 0 ;t . We can also examine
the credible interval (CI) of the posterior to determine whether or not genes g and
g 0 are associated with one another within each treatment group, separately. For a
given level of significance α∗ , two genes will have a significant association when zero is
excluded from the 100(1 − α∗ )% CI. To rank correlations by significance within each
treatment group, we determine the smallest 100(1 − a∗ )% CI that includes 0 for each
gene-gene pair. The corresponding a∗ value indicates the proportion of the posterior
distribution outside of the smallest CI that includes 0, which can be viewed as an
approximate “p-value”.
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When performing differential network analysis, we examine the CIs of the
difference between ρgg0 ;0 and ρgg0 ;1 . If zero is excluded from the 100(1 − α∗ )% CI, the
difference between the treatment correlations for gene g and gene g 0 is significant. An
approximate “p-value” can also be determined and used to rank the differences in
correlation between the treatment groups.

4.3 Results
In our simulation studies, we generated data consistent with our proposed factor
model structure for two treatment groups. Within each treatment t, the Ygi count
was sampled from Poisson(µgi ), with log(µgi ) modeled from Equation (4.1). The
parameters of βg , δg , and λif were all randomly sampled from Normal(0, 1), and we
fixed the values of αgf ;t to create different correlation structures for each treatment
(see Figure 4.1).
We considered G = 50 genes for each dataset, sorted them into ten groups of
five (e.g., Group 1 consisted of genes 1 - 5, Group 2 consisted of genes 6 - 10), and
assigned the same αgf ;t values to all of the genes within each gene group. In two of
the datasets (Sim 1 and Sim 2), we generated N0 = 250 cells in the control group
(t = 0) and N1 = 250 cells in the treatment group (t = 1) for a total of N = 500
cells, and in the other two datasets (Sim 3 and Sim 4), we doubled the number of
cells within each group for a total of N = 1, 000 cells. For the network structures,
Fsim = 10 factors were used to create 350 “true” edges in the control network and
325 “true” edges in the treatment network. In Sim 1 and Sim 3, a total of 250 edges
are considered to be different between the two groups and all of the common edges
have the same direction of correlation (SDC) between the genes pairs (Figures 4.1A
and 4.1B). In Sim 2 and Sim 4, some of the common edges have opposite directions
of correlation (ODC), which increases the “true” number of different edges between
the two groups to be 325 (Figures 4.1C and 4.1D).
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Two versions of our sparse Bayesian factor methodology were investigated in
the simulation studies. In our “base” model version, the priors defined in Equation
(4.2) and Equation (4.3) are placed on the αgf ;t and α
egf parameters, respectively (i.e.,
we use horseshoe priors on the αgf ;t ’s but not on the α
egf ’s). We refer to this model
as Sparse Factor Model - Base Version (SFM-BV). For the second model version, the
prior on each α
egf parameter in Equation (4.3) is replaced with the horseshoe prior
defined in Equation (4.4). We refer to this second model as Sparse Factor Model Additional HorseShoe (SFM-AHS).
Using the simulated data, we ran our proposed models in R (R Core Team,
2018) with the package rstan (Stan Development Team, 2018). Inference was performed after combining the posterior samples from four parallel chains that were run
for a total of 2,000 iterations each, with a burn-in of 1,000 iterations. To investigate
whether the number of factors makes any impact on model performance, we ran both
models four separate times and input a different number of factors for each run: F =
5, 10 (the true number of factors), 15, and 20.
For each simulated dataset, we first used our models to test for a significant
relationship between each gene-gene pair in each treatment by using a 95% CI for
ρgg0 ;t . The significant gene-gene associations identified by SFM-BV and SFM-AHS
were compared to the “true” gene-gene associations, and the measures of true positive rate (TPR), false discovery rate (FDR), and area under the receiver operating
characteristic curve (AUC) were determined for the control network (t = 0) and the
treatment network (t = 1), separately. The results from the four considered choices of
F for our two models are presented in Table 4.1. In all of the simulated datasets, both
SFM-BV and SFM-AHS have high TPRs and AUCs when detecting significant genegene associations within each treatment group. SFM-BV seems to achieve slightly
higher TPRs than SFM-AHS, particularly in the smaller datasets with N = 500 cells
(Sim 1 and Sim 2). When the input number of factors is greater than or equal to
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the true number of factors (i.e., F = 10, 15, or 20), the performances of both models
are relatively consistent across the different performance measures, and both models
control FDRs below 5%. While the choice of F = 5 factors tends to have the highest
TPRs, this choice of F also tends to have the highest FDRs.
To evaluate the performance of differential network analysis with SFM-BV and
SFM-AHS, we examined the 95% CIs of the difference between each ρgg0 ;0 and ρgg0 ;1
pair for each dataset. We also ran analyses with scdNet (Chiu et al., 2018) and the R
package DiffCorr (Fukushima, 2013) to compare our models against other methods.
In scdNet, a sample size adjustment transformation is first applied to the correlation
coefficients within each cellular group and then statistical inference is performed on
the differences in the transformed correlations across groups. The scdNet model is, to
the best of our knowledge, the only other differential network analysis tool currently
available for scRNA-seq. DiffCorr implements Fisher’s Z transformation to compare
correlations between two experimental conditions in the context of bulk population
data. Both scdNet and DiffCorr provide p-values to represent differential results for
each gene-gene pair. To control the FDR, DiffCorr utilizes the local false-discovery
rate approach from Strimmer (2008). For scdNet, we controlled the FDR with the
Benjamini-Hochberg (Benjamini and Hochberg, 1995) procedure. A threshold of 5%
was used to indicate significant differences with these methods.
We compared the significant differences between networks that were identified
by each method to the “true” differences between networks. The measures of TPR,
FDR, AUC, and the number of edges that were classified as significantly different
between networks by each method are displayed in Table 4.2. In addition, we provide
heatmaps to visually represent the “true” differences between treatment groups and
the significant differences detected by each method for Sim 3 (Figure 4.2) and Sim
4 (Figure 4.3). For our methodology, we found that WAIC was better at identifying
top performing models than DIC. Therefore, the number of factors F with the lowest
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WAIC was selected as the “best” model choice for each of our models and only the
results of the “best” model choice for both SFM-BV and SFM-AHS are presented for
each dataset.
From Table 4.2, we see that our differential network methodology performs
quite well in comparison to the other considered methods. Both SFM-BV and SFMAHS outperform DiffCorr in terms of all performance measures across all simulated
datasets. While scdNet tends to detect more significant edges between treatment
groups than the other methods, it also has the highest FDRs. Despite the higher
number of significant edges detected by scdNet, SFM-BV is still able to obtain higher
TPRs than scdNet in three out of the four simulations, while SFM-AHS obtains higher
TPRs than scdNet in two out of the four simulations. In all cases, both SFM-BV and
SFM-AHS have higher AUCs than scdNet while controlling the FDRs to a nominal
level. Also, the heatmaps in Figures 4.2 and 4.3 visually reinforce that our methods
can identify the “true” differential network structure more accurately than the other
two considered methods.
We note that the performances of SFM-BV and SFM-AHS are quite similar
across all performance measures in the larger simulated datasets with N = 1, 000 cells
(Sim 3 and Sim 4). However, for the datasets with N = 500 cells (Sim 1 and Sim 2),
SFM-BV tends to identify more significantly different edges and achieve higher TPRs
than SFM-AHS. Therefore, based on these simulation results, SFM-BV seems to be
the better model choice for our proposed differential network methodology.

4.4 Discussion
In this chapter, we have presented a two-group hierarchical Bayesian factor model
to perform differential network analysis from scRNA-seq data. This work extends
our hierarchical Bayesian factor model for constructing GCNs (Chapter 3) to include
continuous treatment-dependent parameters that determine the impact of the factors
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for each gene. In Chapter 3, our GCN model utilizes a single-treatment α matrix and
the elements of this matrix only take the values of -1, 0, or 1. While this definition is
useful for the interpretation of the factor-gene relationships (i.e., the expression for
gene g is impacted only by factors with |αgf | = 1 and not impacted by factors with
αgf = 0), we are not able to utilize Stan for parameter sampling because Stan cannot
support the use of discrete parameters. Also, the one-at-a-time sampling for the α
matrix does not allow for large scale moves such as splitting or combining factors and
so it is possible for our Markov chain Monte Carlo (MCMC) sampler to get stuck
exploring a local mode of the posterior.
Since the elements of the treatment-dependent αt matrices in our proposed
model for differential network analysis are continuous, we are able to use Stan for
sampling and avoid the problem of getting stuck exploring local modes. The use
of the Stan framework is particularly beneficial because Hamiltonian Monte Carlo
is more accurate and computationally efficient than other MCMC methods (Betancourt, 2017) and the core code for Stan is written in the C++ language, making it
computationally faster than running MCMC sampling code completely in R. As a
future extension, we could also consider using Stan to perform variational inference
(like we did in Chapter 2), since variational inference tends to be much faster than
traditional MCMC techniques. We do note that we are not able to achieve exact
sparsity in the αt matrices because the αgf ;t parameters are continuous. However, we
have adopted a shrinkage approach and use horseshoe priors on the αgf ;t ’s to handle
the expected sparsity.
For simplicity purposes, our methodology has been defined and examined under a two-group situation, but it can be adjusted to fit a multiple group scenario. In
the general case, we can consider T number of treatments and represent the log(µgi )
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from Equation(4.1) in the general form:

log(µgi ) = βg +

T −1
X
t=1

I(ti = t)δg;t +

F
X

λif αgf ;ti −

f =1

F
nX
α2

gf ;ti

f =1

2

o
.

Here, the δg;t parameters depend on the treatment groups t ∈ {1, . . . , T −1} and I(ti =
t) is the indicator variable for cell i being in treatment group t. The construction
of gene-gene correlation structures will remain the same, but there will be T sets
of αgf ;t parameters that create T different networks to compare. When performing
differential network analysis, one can examine the CIs of the difference between ρgg0 ;t
and ρgg0 ;t0 for each pair of treatments t and t0 (t 6= t0 ).
The simulation studies in this manuscript demonstrate that our proposed
methodology is able to accurately identify true co-expression structures with two
treatment groups and detect differences between them. Both SFM-BV and SFM-AHS
outperform competing methods across these simulation studies, but we recommend
using SFM-BV because this model version tends to have higher TPRs when identifying significantly different edges between networks. Based on these results and the
dearth of research in this area, we feel that our methodology serves as one of the first
steps in the development of approaches suitable for scRNA-seq differential network
analysis.
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4.5 Tables and Figures

SFM-BV

F = 5
F = 10
F = 15
F = 20

FDR0
0.132
0.019
0.007
0.007

AUC0
0.986
0.971
0.973
0.969

TPR1
0.994
0.886
0.874
0.874

FDR1
0.146
0.034
0.027
0.027

AUC1
0.999
0.976
0.974
0.976

SFM-AHS

F = 5
F = 10
F = 15
F = 20

0.954
0.823
0.797
0.757

0.100
0.014
0.000
0.004

0.992
0.966
0.950
0.960

0.985
0.855
0.883
0.837

0.221
0.007
0.007
0.000

0.980
0.972
0.971
0.974

SFM-BV

F = 5
F = 10
F = 15
F = 20

TPR0
0.977
0.889
0.869
0.863

FDR0
0.132
0.019
0.007
0.007

AUC0
0.990
0.988
0.970
0.971

TPR1
1.000
0.831
0.806
0.797

FDR1
0.092
0.022
0.022
0.023

AUC1
0.997
0.987
0.978
0.975

SFM-AHS

F = 5
F = 10
F = 15
F = 20

0.980
0.786
0.843
0.786

0.159
0.018
0.013
0.000

0.988
0.948
0.964
0.956

1.000
0.775
0.769
0.735

0.100
0.016
0.020
0.016

0.999
0.971
0.972
0.965

SFM-BV

F = 5
F = 10
F = 15
F = 20

TPR0
0.940
0.949
0.934
0.943

FDR0
0.466
0.035
0.027
0.029

AUC0
0.900
0.988
0.986
0.988

TPR1
1.000
0.975
0.972
0.960

FDR1
0.260
0.019
0.006
0.006

AUC1
0.994
0.999
0.999
0.999

SFM-AHS

Sim 1: SDC, N = 500
TPR0
0.977
0.871
0.871
0.849

F = 5
F = 10
F = 15
F = 20

0.937
0.949
0.929
0.929

0.438
0.012
0.050
0.009

0.916
0.989
0.979
0.984

1.000
0.938
0.982
0.948

0.162
0.000
0.000
0.003

1.000
0.998
1.000
0.998

Sim 2: ODC, N = 500

Sim 3: SDC, N = 1,000

SFM-BV

F = 5
F = 10
F = 15
F = 20

TPR0
0.937
0.954
0.949
0.943

FDR0
0.407
0.023
0.021
0.021

AUC0
0.920
0.993
0.991
0.988

TPR1
1.000
0.972
0.923
0.920

FDR1
0.024
0.009
0.007
0.007

AUC1
1.000
0.999
0.996
0.998

SFM-AHS

Sim 4: ODC, N = 1,000

F = 5
F = 10
F = 15
F = 20

0.937
0.937
0.931
0.934

0.417
0.018
0.015
0.015

0.920
0.981
0.984
0.988

1.000
0.935
0.932
0.914

0.033
0.000
0.000
0.000

1.000
0.997
0.999
0.993

Table 4.1: Performance measures for the identification of significant gene-gene associations by our proposed differential network methods (SFM-BV and SFM-AHS)
with different numbers of factors (F ) across four simulated datasets. TPR, FDR, and
AUC were calculated separately for each treatment group and the subscripts denote
the treatment group of the corresponding network: control = 0, treatment = 1.
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SFM-BV, F = 20
SFM-AHS, F = 20
DiffCorr
scdNet

SFM-BV, F = 15
SFM-AHS, F = 20
DiffCorr
scdNet

SFM-BV, F = 15
SFM-AHS, F = 20
DiffCorr
scdNet

SFM-BV, F = 10
SFM-AHS, F = 20
DiffCorr
scdNet

Sim 1: SDC, N = 500, EdgesT rueD = 250
TPRD
FDRD
AUCD
EdgesD
0.452
0.017
0.814
115
0.096
0.000
0.758
24
0.020
0.167
0.693
6
0.206
0.518
0.641
139
Sim 2: ODC, N = 500, EdgesT rueD = 325
TPRD
FDRD
AUCD
EdgesD
0.671
0.022
0.926
223
0.584
0.010
0.910
192
0.538
0.038
0.900
182
0.462
0.407
0.758
253
Sim 3: SDC, N = 1,000, EdgesT rueD = 250
TPRD
FDRD
AUCD
EdgesD
0.552
0.021
0.943
141
0.532
0.036
0.901
138
0.268
0.163
0.836
80
0.560
0.378
0.819
225
Sim 4: ODC, N = 1,000, EdgesT rueD = 325
TPRD
FDRD
AUCD
EdgesD
0.806
0.022
0.988
268
0.843
0.011
0.976
277
0.646
0.041
0.957
219
0.717
0.272
0.850
320

Table 4.2: Comparison of the “true” differences between networks and the estimated
differences between networks in the simulation studies for each differential network
method. The subscript of “D” is used to denote network differences.
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Figure 4.1: Heatmaps of “true” correlation structures for treatment and control
groups in simulation studies. (A,B) In Sim 1 and Sim 3, all shared edges between the
two groups have the same direction of correlation (SDC). (C,D) In Sim 2 and Sim
4, some shared edges between the two groups have opposite directions of correlation
(ODC).
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Figure 4.2: Heatmaps of the “true” differences between treatment correlation structures in Sim 3 (top) and the significant treatment differences identified by SFM-BV
with F = 15, SFM-AHS with F = 20, DiffCorr, and scdNet. The colored cells indicate
differences in gene-gene associations across the treatment and control groups.
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Figure 4.3: Heatmaps of the “true” differences between treatment correlation structures in Sim 4 (top) and the significant treatment differences identified by SFM-BV
with F = 10, SFM-AHS with F = 20, DiffCorr, and scdNet. The colored cells indicate
differences in gene-gene associations across the treatment and control groups.
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CHAPTER 5
SUMMARY AND FURTHER EXTENSIONS
In this dissertation, we have presented three Bayesian approaches developed specifically for single-cell RNA sequencing (scRNA-seq) analyses. We first defined a hurdle
model for identifying differentially expressed genes across cell types in scRNA-seq data
in Chapter 2. Through several different analyses with both simulated data and real
data, we were able to demonstrate the feasibility and practical utility of our approach
in comparison to alternative methods. Then, in Chapter 3, a sparse Bayesian factor
model was introduced to detect gene-gene network structures from scRNA-seq data.
We highlighted our model’s ability to identify true co-expressions while maintaining
nominal false discovery rates across different numbers of cells and different network
structures in both simulated and real data analyses. Finally, Chapter 4 expanded
upon our sparse Bayesian factor model to examine the differences between networks
of different treatment groups. Again, we were able to establish our methodology’s
superiority over other comparable methods through simulation studies.
These research projects provide significant steps toward the application of
Bayesian solutions to the statistical challenges posed by the characteristics of scRNAseq data. With that being said, we note several further extensions and developments
that are worth considering. For our network methodology in Chapters 3 and 4, a
natural extension would be to place a shrinkage prior on the factor loadings, similar to
the approach used in Bhattacharya and Dunson (2011). This would ultimately remove
the guesswork involved in choosing the number of factors F by allowing, in theory,
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the use of infinitely many factors in our models. Factors with a higher index f will
tend to have smaller variances and, therefore, have smaller overall effects. As another
extension, we could combine differential expression (DE) analysis into our differential
network model from Chapter 4 by performing posterior inference on the log-fold
change parameter δg . Since this model framework utilizes covariance information
between groups, we anticipate achieving higher power and greater efficiency when
detecting differentially expressed genes.
Scalability is perhaps one of the biggest obstacles to overcome when using
Bayesian methodology for high-dimensional scRNA-seq data. Incorporating computationally efficient and scalable algorithms from the existing literature to our proposed
network methodology, like we have done with variational inference for our DE model
in Chapter 2, will allow for analyses of larger gene sets. This will be particularly useful
because Lichtblau et al. (2017) have demonstrated that in the context of bulk population data, differential network algorithms can outperform differential expression
methods in terms of identifying the genes that play key roles in biological processes.
Utilizing a faster programming language (e.g., MATLAB or Julia) could also help reduce the amount of running time required for computationally expensive techniques
like Markov chain Monte Carlo sampling.
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APPENDIX A
HURDLE MODEL SIMULATION DETAILS
Simulated datasets were generated from the hurdle model set-up described in the
Methodology section of the main manuscript. For each small simulation, N = 100
cells were assigned to two different treatment groups: 50 cells allocated to treatment
0 (control) and 50 cells allocated to treatment 1. The cells were further clustered into
ten total subpopulations, such that the cells within each treatment group were evenly
divided into five subpopulations (ten cells in each subpopulation). In the unequal
subpopulation scenario, the five subpopulations consisted of 15, 12, 10, 8, and 5 cells,
respectively. We chose the number of clusters within each treatment to reflect the
number of clusters observed in previous scRNA-seq studies (Patel et al., 2014; Tirosh
et al., 2016) while also including a sufficient number of cells per cluster to reasonably
estimate the correlated random effect parameters within the model. For the larger
simulations, N = 1,000 cells were considered and the number of cells within each
treatment and subpopulation were scaled by a factor of 10.
Letting kt (i) represent the subpopulation of cell i within treatment t, the random effect ωi for each cell was determined by ωi = γt,kt (i) +ωi∗ . The ωi∗ ’s were randomly
generated from N ormal(0, σ∗2 ), with σ∗2 = 0.7. For the unequal simulations, the ωi∗ ’s
from the smallest subpopulation (5 or 50 cells) were drawn from a normal distribution with a smaller variance (σ∗2 = 0.6) and the ωi∗ ’s from the largest subpopulation
(15 or 150 cells) were were drawn from a normal distribution with a larger variance
(σ∗2 = 0.8). To enforce some separation of the random effects between subpopulation
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clusters, the γt,k ’s within each treatment were randomly assigned one of five values
without replacement: −2σt , −σt , 0, σt , and 2σt . In this notation, the true value
of σt represents a scale parameter (not the standard deviation) that determines the
separation between subpopulations. Table A.1 lists the values for σt2 and σ∗2 used in
the simulations.
In the simulation scheme described above, a data-generating design matrix X
consisting only of the treatment indicator was used. The first 1,250 genes, out of G
= 10,000 genes, were set to be significantly different for the logistic regression part of
L
was either -1.5 or 1.5 in the small simulations and either -0.5
the hurdle model (β1g
L
or 0.5 in the large simulations), while the remaining genes had β1g
= 0. The other
L
and ζgL ) were simulated based on the results from the
coefficients in the model (β0g

mouse embryonic cell (MEC) data (Islam et al., 2011). In the large simulations, some
L
’s were set
methods had TPRs and AUCs near 1 when the values of the significant β1g

to ±1.5. Therefore, we decreased the treatment effect to help expose the differences
between methods.
An overlap of 250 differentially expressed (DE) genes between the logistic
regression and the truncated negative binomial regression were considered. Thus,
genes numbered 1,000 − 2,250 in the dataset were set to be significantly different for
C
was either -1.5 or
the zero-truncated negative binomial part of the hurdle model (β1g

1.5 in the small simulations and either -0.5 or 0.5 in the large simulations), while the
C
C
remaining genes had β1g
= 0. The other coefficients in the model (β0g
and ζgC ) were

again simulated based on the results from the MEC data.
Following our proposed methodology, a G × N zero-one matrix Z was first
generated from Bernoulli(θgi ) for each combination of g and i. The probability of
success θgi was determined from Equation (2.1) in the main manuscript using the
coefficients, random effects, and model matrix described above. A G×N count matrix
Y was then generated, such that Ygi = 0 if Zgi = 0, and Ygi > 0 if Zgi = 1. The count
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values for Ygi > 0 were simulated from Truncated Negative Binomial(µgi , φg ) defined
in Equation (2.3) of the main manuscript. Here, µgi was calculated from Equation
(2.4) using the coefficients, random effects, and model matrix described above. The
overdispersion parameter φg was generated from Lognormal(λ1 , λ2 ) with the estimates
of λ1 and λ2 coming from the MEC data. Finally, genes expressed in less than 20%
of all cells were removed from analysis. After data generation, CDR was calculated
and added into the design matrix before model estimation.
For each simulation scenario, 100 datasets were generated and the DE genes
were determined at a false discovery rate (FDR) of 0.05 for each method. SCDE uses
the Holm (1979) procedure to adjust Z-scores, while all other methods utilize the
Benjamini and Hochberg (1995) procedure to control for FDR. The measures of true
positive rate (TPR), false positive rate (FPR), observed FDR, area under the receiver
operating characteristic curve (AUC), and number of identified DE genes were used
to compare methods.
In addition to the simulations discussed in the manuscript, another small sample size simulation (N = 100) was considered by changing the number of subpopulations per treatment group. In one scenario, a total of four subpopulations were
simulated such that the cells within each treatment group were evenly divided into two
subpopulations (twenty-five cells in each cluster). The γt,k ’s within each treatment
were randomly assigned either −0.5σt or 0.5σt without replacement. In the other
scenario, a total of sixteen subpopulations were simulated. We increased the number
of cells per treatment group to be 56 in order to evenly divide the cells in each treatment into eight clusters of seven cells each, and the γt,k ’s within each treatment were
randomly assigned one of nine values without replacement: −2.4σt , −1.8σt , −1.2σt ,
−0.6σt , 0, 0.6σt , 1.2σt , 1.8σt , and 2.4σt . The results from these two variations are
provided in Table A.2.
We also created variation in the small hurdle model simulations by increasing
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the amount of information supplied by the subpopulations. In these simulations we
considered equal cluster sizes and set σ∗2 = 0.3 and σ02 = σ12 = 0.7. Here, the use
of a smaller σ∗2 value creates a larger within subpopulation correlation. Simulated
datasets were generated with two, five, and eight subpopulations per treatment, and
the results are displayed in Table A.3.
The overall results from these variations were generally similar to those already
presented in Section 2.4.1 of the main manuscript. The “2 clusters per treatment”
scenarios were the only small sample size, hurdle model simulations where the bulk
method of DESeq2 selected more DE genes than CRE and IRE. However, this is due
to the much higher FDR in DESeq2, which also leads to worse AUC performance
than our proposal.
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Equal Cluster Size Simulations
Unequal Cluster Size Simulations

σ∗2
0.7
0.8/0.7/0.6

σ02
0.3
0.3

σ12
0.3
0.3

Table A.1: Variance terms for γt,k and ωi∗ in the hurdle model simulation studies.

Hurdle model: 2 equal clusters per treatment
TPR FPR FDR AUC DE Genes
CRE, SC3
0.701 0.009 0.044 0.963
1577
CRE, NN=3
0.700 0.009 0.044 0.963
1577
CRE, NN=7
0.700 0.009 0.044 0.963
1576
CRE, TRUE
0.700 0.009 0.044 0.963
1576
IRE
0.704 0.010 0.043 0.962
1591
NRE
0.694 0.014 0.062 0.958
1595
MAST
0.619 0.006 0.033 0.955
1378
SCDE
0.155 0.088 0.263 0.663
985
DESeq2
0.445 0.118 0.415 0.750
1834
edgeR
0.409 0.062 0.323 0.781
1336
Hurdle model: 8 equal clusters per treatment
TPR FPR FDR AUC DE Genes
CRE, SC3
0.722 0.010 0.046 0.965
1637
CRE, NN=3
0.723 0.010 0.045 0.965
1638
CRE, NN=7
0.722 0.010 0.045 0.965
1635
CRE, TRUE
0.722 0.010 0.045 0.965
1635
IRE
0.726 0.010 0.047 0.965
1646
NRE
0.711 0.024 0.098 0.952
1711
MAST
0.643 0.007 0.037 0.957
1443
SCDE
0.174 0.013 0.276 0.627
1340
DESeq2
0.436 0.088 0.394 0.765
1594
edgeR
0.436 0.071 0.342 0.780
1468

Table A.2: Additional results of performance measures from the hurdle model simulation structure with two and eight simulated subpopulations per treatment.

91

Hurdle model: 2 clusters
TPR
CRE, SC3
0.713
CRE, NN=3
0.713
CRE, NN=7
0.713
CRE, TRUE
0.714
IRE
0.716
NRE
0.713
MAST
0.636
SCDE
0.180
DESeq2
0.490
edgeR
0.401
Hurdle model: 5 clusters
TPR
CRE, SC3
0.663
CRE, NN=3
0.663
CRE, NN=7
0.663
CRE, TRUE
0.663
IRE
0.667
NRE
0.647
MAST
0.568
SCDE
0.031
DESeq2
0.380
edgeR
0.360
Hurdle model: 8 clusters
TPR
CRE, SC3
0.701
CRE, NN=3
0.701
CRE, NN=7
0.701
CRE, TRUE
0.702
IRE
0.704
NRE
0.686
MAST
0.611
SCDE
0.048
DESeq2
0.425
edgeR
0.408

per treatment, high correlation
FPR FDR AUC DE Genes
0.009 0.042 0.965
1595
0.009 0.041 0.965
1595
0.009 0.041 0.965
1594
0.009 0.042 0.965
1597
0.010 0.045 0.965
1609
0.010 0.048 0.964
1606
0.006 0.032 0.958
1409
0.064 0.377 0.686
861
0.202 0.500 0.715
2545
0.030 0.197 0.811
1078
per treatment, high correlation
FPR FDR AUC DE Genes
0.009 0.043 0.955
1506
0.009 0.043 0.955
1506
0.009 0.043 0.955
1504
0.009 0.043 0.955
1506
0.010 0.048 0.954
1524
0.015 0.074 0.945
1522
0.006 0.037 0.944
1281
0.008 0.066 0.677
126
0.048 0.298 0.778
1183
0.053 0.335 0.768
1181
per treatment, high correlation
FPR FDR AUC DE Genes
0.010 0.047 0.959
1596
0.010 0.048 0.959
1599
0.010 0.047 0.959
1598
0.010 0.047 0.959
1597
0.010 0.048 0.960
1606
0.021 0.092 0.948
1647
0.007 0.040 0.949
1381
0.014 0.134 0.657
207
0.075 0.361 0.770
1480
0.075 0.378 0.761
1447

Table A.3: Additional results of performance measures from the hurdle model simulation structure with high within subpopulation correlation for two, five, and eight
subpopulations per treatment.
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APPENDIX B
SPLAT SIMULATION DETAILS
The Splat scheme (Zappia et al., 2017) simulates count expression values from a
gamma-Poisson distribution that is modified to vary the library sizes across cells and
impose a mean-variance trend such that highly expressed genes are less variable than
lowly expressed genes. This simulation structure also provides options for including
abnormally high expression levels (outlier genes), high proportions of zeros (dropout),
and additional technical variation (batch effects). For simulating differential expression between treatment groups of cells, Splat generates multiplicative factors from
a lognormal distribution and applies them to the mean expression values of the respective genes in one of the treatment groups. Genes not simulated to be DE have
multiplicative factors set to one.
A total of 100 small datasets (100 cells and 10,000 genes) and 100 larger
datasets (1,000 cells and 10,000 genes) were generated with the splatSimulateGroups
function from the Splatter R package (Zappia et al., 2017). The probability of a gene
being DE was set to 0.1, and cells had equal probabilities of being assigned to one of
two groups. We considered additional technical variation by setting the batch effect
argument such that half of the cells belonged in one batch and the other half belonged
in another batch. Dropout and outlier genes were also incorporated into the Splat
simulation design.
The location parameters for the lognormal distributions of the batch effects
factor and differential expression factor were both set to 2, while the scale parameters
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for both factors set to their default values of 0.1 and 0.4, respectively. Again, in the
larger datasets we observed very high TPRs and AUCs (nearly 1) for some of the
methods when the expression factor was set to 2. Therefore, to help differentiate the
methods in the larger Splat datasets, the differential expression factor was reduced
to 0.5. Values for the remaining parameters of the splatSimulateGroups function not
already mentioned above were estimated from the MEC data, and genes that were
not expressed in at least 20% of the cells were removed from analysis.
In addition to using trimmed mean of M-values normalization and scaling the
adjusted counts to counts per million for the clustering algorithms, as described in
Section 2.4 of the main manuscript, we also applied the mutual nearest neighbors
(MNN) correction (Haghverdi et al., 2018) to adjust for batch effects. The MNN
method is available in the scran R package (Lun et al., 2016).
Since we focus on how the results from a clustering analysis can be incorporated
into our model, not on how to perform a cluster analysis, we do assume that some
consideration for potential bias has been taken when processing the data for clustering. Therefore, we included the MNN adjustment to remove any bias the simulated
batch effects may impose during clustering. However, to keep the Splat simulation
analyses consistent across all methods, we did not apply the MNN adjustment to the
data analyzed with MAST since we did not adjust any of the other models for batch
effects.
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APPENDIX C
HMEC DROP-SEQ DETAILS
This dataset was generously provided to us by researchers at the University of Florida
Health Cancer Center. To measure the cell-to-cell variability of gene expression in
a mammalian cell line, Drop-seq was used to perform single cell expression analysis
on MCF10A human mammary epithelial cells (HMEC) expressing either exogenous
wild type or mutant histone H2B. Each sample included 10% mouse 3T3 cells to
assist in determining the doublet rate and ambient RNA barcode noise. The Dropseq apparatus was constructed in house according to published protocols (Macosko
et al., 2015) with a microfluidic co-flow device purchased from Nanoshift (Emeryville,
CA).
Briefly, 1,000 cells were encapsulated in droplets with companion bar coded
primer-coated microparticles. After cell lysis, cDNA libraries were prepared by hybridization of mRNA to primer beads and reverse transcriptase treatment with Maxima H Minus RT (ThermoFisher) to produce single-cell transcriptomes attached to
microparticles (STAMPS) and amplified with Kapa HiFi Hotstart ReadyMix. The
cDNA library was tagmented with Nextara XT to produce pools high throughput
sequencing on a NextSeq 500 (Illumina) with a 75 bp flow cell.
A cluster analysis was performed on this data to examine the variability within
potential subpopulations of cells. In brief, the SC3 algorithm (Kiselev et al., 2017) was
utilized to initially estimate an “optimal” number of clusters within each cell type.
A visual inspection was then imposed to ensure that each cluster had a reasonable
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number of cells (at least 1% of the total number of cells). Based on this analysis, the
wild type cells were clustered into seven subpopulations and the mutant cells were
clustered into nine subpopulations.
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APPENDIX D
ADDITIONAL MEC ANALYSES

Sensitivity Analysis
To evaluate the choice of Inverse Gamma(0.001, 0.001) as the prior on λ2 , we ran an
additional analysis on the MEC data after changing this prior to Inverse Gamma(1, 1)
in our models. With the new prior, CRE detected 4,933 DE genes compared to the
4,927 DE genes in the original analysis. The overlap of genes was 4,926. For the IRE
model, both versions identified exactly 4,947 DE genes, with 100% overlap. Based on
these results, the prior choice for λ2 seems to be relatively innocuous.

DAVID Functional Annotation Clustering
The Database for Annotation, Visualization, and Integrated Discovery, better known
as DAVID (Huang et al., 2009a,b), was utilized to help determine the biological
relevance of genes identified as being DE in the MEC analysis. Clusters of gene
ontology (GO) categories for different subsets of genes were created with the DAVID
functional annotation clustering tool. An Enrichment Score is calculated by DAVID
for each cluster to help identify clusters that are involved in more enriched (important)
biological roles. Each Enrichment Score is determined by the geometric mean of the
modified Fisher Exact p-values for all annotation terms that belong to a given cluster.
A negative log base 10 transformation is applied on each geometric mean to emphasize
that this measurement is a relative score, rather than an exact value. Thus, a higher
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score indicates that the genes annotated to the GO categories within the cluster are
involved in more enriched roles.
It has been recommended that more attention should be given to groups with
scores greater than or equal to 1.3 (Huang et al., 2009b). An Enrichment Score of
1.3 corresponds to clusters with a geometric mean of 10−1.3 = 0.05. We used this
threshold of 1.3 to classify clusters as enriched. Additionally, we made special note
of the clusters with Enrichment Scores greater than or equal to 4 (i.e., the geometric
mean of p-values is 10−4 or less) by classifying them as highly enriched.
We examined the 1,335 genes in the MEC analysis that were detected by CRE
and undetected in the other methods to help evaluate the biological relevance of these
new discoveries. For comparison, we also analyzed the genes uniquely identified by
only DESeq2 and only edgeR. These methods were chosen as a comparison because
they detected the second (293) and third (172) highest number of unique DE genes.
The scRNA-seq methods of SCDE and MAST only detected 7 and 2 unique genes,
respectively.
A total of five GO category clusters were considered to be highly enriched in
the analysis of genes identified only CRE, and twenty additional clusters had scores
greater than 1.3. Categories of RNA splicing, mRNA processing, and spliceosomal
complex were clustered together and had the highest Enrichment Score of 10.62. The
cluster containing GO categories of relating to cell-cell adhesion had the second highest Enrichment Score (7.13) and the cluster containing categories related to DNA
binding and transcription both had the third highest Enrichment Score (7.10). GO
categories of cell cycle, mitotic nuclear division, and cell division were clustered together had an Enrichment Score of 4.73. Lastly, the fifth most highly enriched cluster
had an Enrichment Score of 4.51 and included categories relating to ligase activity
and protein ubiquitination.
In comparison, the genes detected only by DESeq2 had one highly enriched GO
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category cluster and five clusters with scores greater than 1.3. The highly enriched
cluster had an Enrichment Score of 4.63 and contained categories related to RNA
binding. The genes identified only by edgeR did not have any highly enriched GO
clusters, but did have two clusters with a score greater than 1.3.
Naturally, we would expect the genes detected by our CRE model to form more
clusters simply because there are more of them, but the fact that five of GO category
clusters were highly enriched and twenty more had Enrichment Scores greater than
1.3 suggests that many of these genes have similarities in their biological roles. The
subset of 989 genes in common among all methods except for MAST did form ten
GO clusters with Enrichment Scores greater than 1.3, but none of them had a score
greater than 4. Additionally, the 1,148 genes in common among CRE, DESeq2, and
edgeR formed fourteen GO clusters with scores greater than 1.3 with two of those
clusters being highly enriched. Therefore, based on the comparison to these larger
subsets, our CRE method is not only able to identify a larger number of DE genes,
but these genes are also annotated to similar and important biological functions and
processes.
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